☰

Cynthia M. Gibson, Ph.D. - Publications

Affiliations: 
2005 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
General, Social Work, Public and Social Welfare
Tree Info Similar researchers PubMed Report error

419 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Butala NM, Faridi KF, Tamez H, Strom JB, Song Y, Shen C, Secemsky EA, Mauri L, Kereiakes DJ, Curtis JP, Gibson CM, Yeh RW. Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings from the EXTEND-DAPT Study. Circulation. PMID 34743530 DOI: 10.1161/CIRCULATIONAHA.121.056878  0.346
2021 Jensen IS, Wu E, Cyr PL, Claussen M, Winkler T, Salahuddin K, Prats J, Mahaffey KW, Gibson CM, Steg PG, Stone GW, Bhatt DL. Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. PMID 34331235 DOI: 10.1007/s40256-021-00491-9  0.337
2021 Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, et al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. Bmj (Clinical Research Ed.). 373: n1332. PMID 34135011 DOI: 10.1136/bmj.n1332  0.308
2021 Bor WL, Zheng KL, Tavenier AH, Gibson CM, Granger CB, Bentur O, Lobatto R, Postma S, Coller BS, van 't Hof AWJ, Ten Berg JM. Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. PMID 34031019 DOI: 10.4244/EIJ-D-21-00287  0.351
2021 Vogel B, Baber U, Cohen DJ, Sartori S, Sharma SK, Angiolillo DJ, Farhan S, Goel R, Zhang Z, Briguori C, Collier T, Dangas G, Dudek D, Escaned J, Gil R, ... ... Gibson CM, et al. Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. Jama Cardiology. PMID 33991416 DOI: 10.1001/jamacardio.2021.1720  0.403
2021 Butala NM, Faridi KF, Secemsky EA, Song Y, Curtis J, Gibson CM, Kazi D, Shen C, Yeh RW. Prognosis of Claims- Versus Trial-Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting. Journal of the American Heart Association. e018744. PMID 33682431 DOI: 10.1161/JAHA.120.018744  0.316
2021 Fabris E, Korjian S, Coller B, Ten Berg JM, Granger CB, Gibson CM, Van't Hof A. Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead. Thrombosis and Haemostasis. PMID 33677829 DOI: 10.1055/a-1414-5009  0.38
2021 Valgimigli M, Mehran R, Franzone A, da Costa BR, Baber U, Piccolo R, McFadden EP, Vranckx P, Angiolillo DJ, Leonardi S, Cao D, Dangas GD, Mehta SR, Serruys PW, Gibson CM, et al. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis. Jacc. Cardiovascular Interventions. 14: 444-456. PMID 33602441 DOI: 10.1016/j.jcin.2020.11.046  0.338
2021 Angiolillo DJ, Bhatt DL, Cannon CP, Eikelboom JW, Gibson CM, Goodman SG, Granger CB, Holmes DR, Lopes RD, Mehran R, Moliterno DJ, Price MJ, Saw J, Tanguay JF, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update. Circulation. 143: 583-596. PMID 33555916 DOI: 10.1161/CIRCULATIONAHA.120.050438  0.349
2021 Beerkens F, Cao D, Dangas G, Sartori S, Zhang Z, Nicolas J, Camaj A, Claessen B, Pivato CA, Power D, Razuk V, Jones D, Angiolillo D, Mehta S, Gibson CM, et al. TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis Journal of the American College of Cardiology. 78: B15-B16. DOI: 10.1016/j.jacc.2021.09.888  0.343
2020 Peterson BE, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, et al. Reduction in Revascularization with Icosapent Ethyl: Insights from REDUCE-IT REVASC. Circulation. PMID 33148016 DOI: 10.1161/CIRCULATIONAHA.120.050276  0.387
2020 Gargiulo G, Cannon CP, Gibson CM, Goette A, Lopes RD, Oldgren J, Korjian S, Windecker S, Esposito G, Vranckx P, Valgimigli M. Safety and efficacy of double versus triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of NOAC-based randomized clinical trials. European Heart Journal. Cardiovascular Pharmacotherapy. PMID 33119069 DOI: 10.1093/ehjcvp/pvaa116  0.4
2020 Baber U, Dangas G, Angiolillo DJ, Cohen DJ, Sharma SK, Nicolas J, Briguori C, Cha JY, Collier T, Dudek D, Džavik V, Escaned J, Gil R, Gurbel P, Hamm CW, ... ... Gibson CM, et al. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. European Heart Journal. 41: 3533-3545. PMID 33085967 DOI: 10.1093/eurheartj/ehaa670  0.422
2020 Gibson CM, Kastelein JJP, Phillips AT, Aylward PE, Yee MK, Tendera M, Nicholls SJ, Pocock S, Goodman SG, Alexander JH, Lincoff AM, Bode C, Duffy D, Heise M, Berman G, et al. Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. American Heart Journal. PMID 33065120 DOI: 10.1016/j.ahj.2020.10.052  0.378
2020 Capodanno D, Morice MC, Angiolillo DJ, Bhatt DL, Byrne RA, Colleran R, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, et al. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. Journal of the American College of Cardiology. 76: 1468-1483. PMID 32943165 DOI: 10.1016/j.jacc.2020.06.085  0.318
2020 Tamez H, Secemsky EA, Valsdottir LR, Moussa ID, Song Y, Simonton CA, Gibson CM, Popma JJ, Yeh RW. Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention among Medicare Beneficiaries. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. PMID 32863243 DOI: 10.4244/Eij-D-19-01031  0.312
2020 Kereiakes DJ, Henry TD, DeMaria AN, Bentur O, Carlson M, Seng Yue C, Martin LH, Midkiff J, Mueller M, Meek T, Garza D, Gibson CM, Coller BS. First Human Use of RUC-4: A Nonactivating Second-Generation Small-Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point-of-Care Treatment of ST-Segment-Elevation Myocardial Infarction. Journal of the American Heart Association. 9: e016552. PMID 32844723 DOI: 10.1161/JAHA.120.016552  0.372
2020 Capodanno D, Di Maio M, Greco A, Bhatt DL, Gibson CM, Goette A, Lopes RD, Mehran R, Vranckx P, Angiolillo DJ. Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Journal of the American Heart Association. 9: e017212. PMID 32805186 DOI: 10.1161/JAHA.120.017212  0.332
2020 Dangas G, Baber U, Sharma S, Giustino G, Mehta S, Cohen D, Angiolillo D, Sartori S, Chandiramani R, Briguori C, Dudek D, Escaned J, Huber K, Collier T, Kornowski R, ... ... Gibson CM, et al. Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis. Journal of the American College of Cardiology. PMID 32240761 DOI: 10.1016/j.jacc.2020.03.011  0.316
2020 Angiolillo DJ, Baber U, Sartori S, Briguori C, Dangas G, Cohen DJ, Mehta SR, Gibson CM, Chandiramani R, Huber K, Kornowski R, Weisz G, Kunadian V, Oldroyd KG, Ya-Ling H, et al. Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. PMID 32240760 DOI: 10.1016/j.jacc.2020.03.008  0.331
2020 Sorrentino S, Sartori S, Baber U, Claessen BE, Giustino G, Chandrasekhar J, Chandiramani R, Cohen DJ, Henry TD, Guedeney P, Ariti C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, et al. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry. Circulation. Cardiovascular Interventions. 13: e008226. PMID 32216472 DOI: 10.1161/CIRCINTERVENTIONS.119.008226  0.342
2020 Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Vranckx P, Goette A, Gibson CM, Alexander JH. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. Jama Cardiology. PMID 32101251 DOI: 10.1001/Jamacardio.2019.6175  0.334
2020 Yip C, Seneviratna A, Tan SH, Khaing T, Chan SP, Loh J, Lee CH, Low AF, Drum CL, Poh SC, Gibson CM, Ohman EM, Richards AM, Chan MY. Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation. Journal of Thrombosis and Thrombolysis. PMID 32077007 DOI: 10.1007/s11239-020-02066-y  0.361
2020 Kazmi SHA, Datta S, Chi G, Nafee T, Yee M, Kalia A, Sharfaei S, Shojaei F, Mirwais S, Gibson CM. The AngelMed Guardian System in the Detection of Coronary Artery Occlusion: Current Perspectives. Medical Devices (Auckland, N.Z.). 13: 1-12. PMID 32021496 DOI: 10.2147/MDER.S219865  0.394
2020 Chang A, Gibson CM. Current Assessments of the Adequacy of Myocardial Perfusion During Acute MI. Current Treatment Options in Cardiovascular Medicine. 7: 25-34. PMID 15913501 DOI: 10.1007/S11936-005-0003-5  0.418
2020 Guerra DR, Gibson CM. Door-to-Balloon Delays with PCI in Acute Myocardial Infarction. Current Treatment Options in Cardiovascular Medicine. 6: 69-77. PMID 15023286 DOI: 10.1007/S11936-004-0016-5  0.408
2020 Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum S, Juliano R, Jiao L, Doyle R, Granowitz C, Gibson CM, Pinto DS, Giugliano RP, Budoff MJ, et al. Abstract 14997: Icosapent Ethyl Reduces Ischemic Events in Patients With Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG Circulation. 142. DOI: 10.1161/circ.142.suppl_3.14997  0.405
2019 Alkhalfan F, Nafee T, Yee MK, Chi G, Kalayci A, Plotnikov A, Braunwald E, Gibson CM. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial). The American Journal of Cardiology. PMID 31898965 DOI: 10.1016/J.Amjcard.2019.12.007  0.328
2019 Sarma AA, Braunwald E, Cannon CP, Guo J, Im K, Antman EM, Gibson CM, Newby LK, Giugliano RP, Morrow DA, Wiviott SD, Sabatine MS, O'Donoghue ML. Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology. 74: 3013-3022. PMID 31865968 DOI: 10.1016/J.Jacc.2019.09.065  0.326
2019 Sullivan AE, Nanna MG, Rao SV, Cantrell S, Gibson CM, Verheugt FWA, Peterson ED, Lopes RD, Alexander JH, Granger CB, Yee MK, Kong DF. A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 31713326 DOI: 10.1002/ccd.28535  0.336
2019 Bhatt DL, Miller M, Brinton EA, Jacobson TA, Steg PG, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif JC, Olshansky B, Chung MK, Gibson CM, Giugliano RP, et al. REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States. Circulation. PMID 31707829 DOI: 10.1161/Circulationaha.119.044440  0.315
2019 Holmes DR, Krucoff MW, Mullin C, Mikdadi G, Presser D, Wohns D, Kaplan A, Ciuffo A, Eberly AL, Iteld B, Fischell DR, Fischell T, Keenan D, John MS, Gibson CM. Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events. Journal of the American College of Cardiology. 74: 2047-2055. PMID 31623762 DOI: 10.1016/j.jacc.2019.07.084  0.346
2019 Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Džavík V, Escaned J, Gil R, Gurbel P, Hamm CW, ... ... Gibson CM, et al. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. The New England Journal of Medicine. PMID 31556978 DOI: 10.1056/NEJMoa1908419  0.353
2019 Kandzari DE, Lembo NJ, Carlson HD, Kalynych A, Spertus JA, Gibson CM, Chi G, Morgan J, Rinehart S, Yehya A, Qian Z, Ajose B, Karmpaliotis D. Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 31512377 DOI: 10.1002/ccd.28494  0.317
2019 Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. Jama Cardiology. PMID 31215979 DOI: 10.1001/Jamacardio.2019.1880  0.384
2019 Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, et al. ST-segment elevation myocardial infarction. Nature Reviews. Disease Primers. 5: 39. PMID 31171787 DOI: 10.1038/s41572-019-0090-3  0.451
2019 Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. European Heart Journal. PMID 31116395 DOI: 10.1093/eurheartj/ehz372  0.315
2019 Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, et al. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk. Circulation. PMID 31116032 DOI: 10.1161/CIRCULATIONAHA.119.040167  0.315
2019 Duran JM, Naderi S, Vidula M, Michalak N, Chi G, Lindsay M, Ghoshhajra B, Gibson CM, Wood MJ. Spontaneous coronary artery dissection and its association with takotsubo syndrome: Novel insights from a tertiary center registry. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 31037831 DOI: 10.1002/Ccd.28314  0.323
2019 Faggioni M, Baber U, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Claessen BE, Dangas GD, Gibson CM, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, et al. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention. Circulation. Cardiovascular Interventions. 12: e007133. PMID 30998384 DOI: 10.1161/CIRCINTERVENTIONS.118.007133  0.354
2019 Gibson CM, Holmes D, Mikdadi G, Presser D, Wohns D, Yee MK, Kaplan A, Ciuffo A, Eberly AL, Iteld B, Krucoff MW. Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. PMID 30842028 DOI: 10.1016/j.jacc.2019.01.014  0.381
2019 Kerneis M, Yee MK, Mehran R, Nafee T, Bode C, Halperin JL, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Fox KAA, Gibson CM. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention. Circulation. Cardiovascular Interventions. 12: e007124. PMID 30704287 DOI: 10.1161/Circinterventions.118.007124  0.326
2019 Gibson WJ, Gibson CM, Yee MK, Korjian S, Daaboul Y, Plotnikov AN, Burton P, Braunwald E. Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51 Journal of the American Heart Association. 8. DOI: 10.1161/Jaha.118.009451  0.352
2019 Bikdeli B, Chatterjee S, Kirtane A, Parikh S, Andreozzi G, Gibson CM, Goldhaber S, Eikelboom J, Krumholz HM, Stone G. CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING SULODEXIDE VERSUS CONTROL: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Journal of the American College of Cardiology. 73: 144. DOI: 10.1016/S0735-1097(19)30752-1  0.323
2019 Shahim B, Chen S, Crowley A, Redfors B, Mehdipoor G, Ben-Yehuda O, Witzenbichler B, Maehara A, Gibson CM, Stone G. TCT-518 Utility of Troponin and Creatine Kinase in Predicting Myocardial Infarct Size, Left Ventricular Dysfunction, and Clinical Outcomes After Acute Anterior Myocardial Infarction: The INFUSE-AMI Trial Journal of the American College of Cardiology. 74: B512. DOI: 10.1016/j.jacc.2019.08.618  0.371
2018 Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, ... Gibson C, et al. Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. The American Journal of Cardiology. PMID 30612724 DOI: 10.1016/j.amjcard.2018.11.051  0.365
2018 Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention. Circulation. 138: 527-536. PMID 30571525 DOI: 10.1161/CIRCULATIONAHA.118.034722  0.367
2018 Korjian S, Braunwald E, Daaboul Y, Mi M, Bhatt DL, Verheugt FWA, Cohen M, Bode C, Burton P, Plotnikov AN, Gibson CM. Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). The American Journal of Cardiology. PMID 30340765 DOI: 10.1016/J.Amjcard.2018.08.034  0.368
2018 Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O'Donoghue ML, Antman EM, Newby LK, Sabatine MS, et al. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. European Heart Journal. PMID 30239711 DOI: 10.1093/Eurheartj/Ehy556  0.345
2018 Gibson CM, Levitan B, Gibson WJ, Yee MK, Murphy SA, Yuan Z, Chakrabarti AK, Lee M, Braunwald E. Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome. Journal of the American College of Cardiology. 72: 129-136. PMID 29976285 DOI: 10.1016/J.Jacc.2018.04.055  0.356
2018 Olivier CB, Sundaram V, Bhatt DL, Leonardi S, Lopes RD, Ding VY, Yang L, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, White HD, Desai M, Lynch DR, et al. Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials. International Journal of Cardiology. PMID 29937301 DOI: 10.1016/j.ijcard.2018.06.034  0.418
2018 Baber U, Li SX, Pinnelas R, Pocock SJ, Krucoff MW, Ariti C, Gibson CM, Steg PG, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Iakovou I, et al. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients). Circulation. Cardiovascular Interventions. 11: e006144. PMID 29870385 DOI: 10.1161/CIRCINTERVENTIONS.117.006144  0.324
2018 Tricoci P, Newby LK, Clare RM, Leonardi S, Gibson CM, Giugliano RP, Armstrong PW, Van de Werf F, Montalescot G, Moliterno DJ, Held C, Aylward PE, Wallentin L, Harrington RA, Braunwald E, et al. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. Jacc. Cardiovascular Interventions. 11: 856-864. PMID 29747915 DOI: 10.1016/J.Jcin.2018.02.006  0.449
2018 Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS. Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 29726596 DOI: 10.1002/ccd.27638  0.323
2018 Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, et al. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. Jacc. Cardiovascular Interventions. PMID 29550085 DOI: 10.1016/J.Jcin.2017.11.009  0.346
2018 Kerneis M, Talib U, Nafee T, Daaboul Y, Pahlavani S, Pitliya A, Furqan MM, Datta S, Kazmi HA, Younes A, Gibson CM. Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention. Progress in Cardiovascular Diseases. PMID 29397950 DOI: 10.1016/j.pcad.2018.01.008  0.311
2018 Gibson CM, Nafee T, Kerneis M. Silent Myocardial Infarction: Listen to the Evidence. Journal of the American College of Cardiology. 71: 9-11. PMID 29301632 DOI: 10.1016/j.jacc.2017.10.069  0.348
2018 Olivier C, Abnousi F, Sundaram V, Yang J, Stone G, Steg P, Gibson CM, Hamm C, Price M, Deliargyris E, Prats J, White H, Harrington R, Bhatt D, Mahaffey K, et al. THE EFFICACY AND SAFETY OF CANGRELOR FOR PATIENTS UNDERGOING SINGLE VESSEL VERSUS MULTI VESSEL PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CHAMPION PHOENIX TRIAL Journal of the American College of Cardiology. 71: A29. DOI: 10.1016/S0735-1097(18)30570-9  0.326
2018 Sullivan A, Nanna M, Rao S, Cantrell S, Gibson CM, Verheugt F, Peterson E, Yee M, Kong D. TCT-775 A Systematic Review of Randomized and Non-randomized Studies Comparing Dual Therapy with Triple Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Journal of the American College of Cardiology. 72: B309. DOI: 10.1016/J.JACC.2018.08.2005  0.316
2017 Korjian S, Braunwald E, Daaboul Y, Verheugt F, Bode C, Tendera M, Jain P, Plotnikov A, Burton P, Gibson CM. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. European Heart Journal. Acute Cardiovascular Care. 2048872617745003. PMID 29249166 DOI: 10.1177/2048872617745003  0.396
2017 Shah B, Baber U, Pocock SJ, Krucoff MW, Ariti C, Gibson CM, Steg PG, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Iakovou I, Dangas G, et al. White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry). Circulation. Cardiovascular Interventions. 10. PMID 28916600 DOI: 10.1161/CIRCINTERVENTIONS.117.004981  0.381
2017 Giustino G, Redfors B, Brener SJ, Kirtane AJ, Généreux P, Maehara A, Dudek D, Neunteufl T, Metzger DC, Crowley A, Mehran R, Gibson CM, Stone GW. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. European Heart Journal. Acute Cardiovascular Care. 2048872617719649. PMID 28828881 DOI: 10.1177/2048872617719649  0.39
2017 Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, et al. Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. International Journal of Cardiology. PMID 28634037 DOI: 10.1016/j.ijcard.2017.06.040  0.355
2017 Chandrasekhar J, Baber U, Sartori S, Aquino M, Tomey M, Kruckoff M, Moliterno D, Henry TD, Weisz G, Gibson CM, Iakovou I, Kini A, Faggioni M, Vogel B, Farhan S, et al. Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. International Journal of Cardiology. PMID 28554669 DOI: 10.1016/j.ijcard.2017.05.049  0.382
2017 Parker WA, Bhatt DL, Prats J, Day JR, Steg PG, Stone GW, Hamm CW, Mahaffey KW, Price MJ, Gibson CM, White HD, Storey RF. Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study. Thrombosis and Haemostasis. PMID 28382371 DOI: 10.1160/TH16-12-0958  0.334
2017 Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, ... ... Gibson CM, et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet (London, England). PMID 28325638 DOI: 10.1016/S0140-6736(17)30751-1  0.377
2017 Fanaroff AC, Hasselblad V, Roe MT, Bhatt DL, James SK, Steg PG, Gibson CM, Ohman EM. Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis. International Journal of Cardiology. PMID 28320608 DOI: 10.1016/j.ijcard.2017.03.046  0.336
2017 Tamez H, Pinto DS, Kirtane AJ, Litherland C, Yeh RW, Dangas GD, Mehran R, Deliargyris EN, Ortiz G, Gibson CM, Stone GW. Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial. Jama Cardiology. PMID 28249084 DOI: 10.1001/jamacardio.2016.5669  0.437
2017 Chi G, Korjian S, Daaboul Y, Nafee T, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Eickels M, Lip GYH, Cohen M, Peterson E, Fox KAA, Gibson CM. P6112Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx493.P6112  0.329
2017 Shah B, Baber U, Krucoff M, Aquino M, Henry T, Gibson CM, Moliterno D, Steg PG, Stuckey T, Pocock S, Dangas G, Ariti C, Witzenbichler B, Cohen D, Iakovou I, et al. WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY Journal of the American College of Cardiology. 69: 119. DOI: 10.1016/S0735-1097(17)33508-8  0.311
2017 Olivier C, Sundaram V, Ding V, Yang L, Leonardi S, Lopes R, Bhatt D, Stone G, Steg P, Gibson CM, Hamm C, Price M, White H, Desai M, Harrington R, et al. ONE-YEAR MORTALITY INCREASED IN PATIENTS WITH PERI-PROCEDURAL MYOCARDIAL INFARCTION: INSIGHTS FROM THE CHAMPION TRIALS Journal of the American College of Cardiology. 69: 7. DOI: 10.1016/S0735-1097(17)33396-X  0.342
2017 Genereux P, Redfors B, Stone G, Steg PG, Gibson CM, Hamm C, Price M, Prats J, White H, Bhatt D. TCT-724 Impact of Coronary Calcification Severity on Clinical Outcomes After Contemporary PCI – Insights From the CHAMPION PHOENIX Trial Journal of the American College of Cardiology. 70: B308-B309. DOI: 10.1016/J.JACC.2017.09.961  0.333
2017 Kereiakes D, Lepor N, Gerber R, Lee LV, Thompson D, Gibson CM. TCT-586 Alirocumab efficacy and safety in patients with prior coronary revascularization Journal of the American College of Cardiology. 70: B242-B243. DOI: 10.1016/J.JACC.2017.09.770  0.308
2017 Sorrentino S, Snyder C, Baber U, Giustino G, Sartori S, Farhan S, Vogel B, Chandrasekhar J, Ge Z, Levine H, Cohen D, Ariti C, Gibson CM, Krucoff M, Moliterno D, et al. TCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry Journal of the American College of Cardiology. 70: B39. DOI: 10.1016/j.jacc.2017.09.145  0.341
2016 Faggioni M, Chandrasekhar J, Baber U, Vogel B, Moliterno D, Henry T, Steg PG, Colombo A, Gibson C, Pocock S, Witzenbichler B, Chieffo A, Cohen D, Weisz G, Kini A, et al. TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 68: B89. PMID 27970393 DOI: 10.1016/j.jacc.2016.09.270  0.305
2016 Giustino G, Redfors B, Brener S, Kirtane A, Généreux P, Maehara A, Neunteufl T, Metzger DC, Mehran R, Gibson CM, Stone G. TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial. Journal of the American College of Cardiology. 68: B68. PMID 27970335 DOI: 10.1016/j.jacc.2016.09.308  0.405
2016 Gargiulo G, Windecker S, Vranckx P, Gibson CM, Mehran R, Valgimigli M. A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More? Circulation. 134: 1881-1906. PMID 27920074 DOI: 10.1161/CIRCULATIONAHA.116.023952  0.359
2016 Baber U, Dangas G, Cohen DJ, Gibson CM, Mehta SR, Angiolillo DJ, Pocock SJ, Krucoff MW, Kastrati A, Ohman EM, Steg PG, Badimon J, Zafar MU, Chandrasekhar J, Sartori S, et al. Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. American Heart Journal. 182: 125-134. PMID 27914492 DOI: 10.1016/j.ahj.2016.09.006  0.354
2016 Welsh RC, Roe MT, Steg PG, James S, Povsic TJ, Bode C, Gibson CM, Ohman EM. A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease. American Heart Journal. 181: 92-100. PMID 27823698 DOI: 10.1016/j.ahj.2016.08.008  0.318
2016 Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. Circulation. Cardiovascular Interventions. 9. PMID 27803042 DOI: 10.1161/CIRCINTERVENTIONS.116.004395  0.368
2016 Gibson CM, Korjian S, Tricoci P, Daaboul Y, Alexander JH, Steg PG, Lincoff AM, Kastelein JJ, Mehran R, D'Andrea D, Merkely B, Zarebinski M, Ophius TO, Harrington RA. Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction. American Heart Journal. 180: 22-8. PMID 27659879 DOI: 10.1016/J.Ahj.2016.06.017  0.348
2016 Gennaro G, Brener SJ, Redfors B, Kirtane AJ, Généreux P, Maehara A, Neunteufl T, Metzger DC, Mehran R, Gibson CM, Stone GW. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). The American Journal of Cardiology. PMID 27553094 DOI: 10.1016/j.amjcard.2016.07.019  0.306
2016 Leonardi S, Lopes RD, Steg PG, Abnousi F, Menozzi A, Prats J, Mangum S, Wilson M, Todd M, Stone GW, Gibson CM, Hamm CW, Price MJ, White HD, Harrington RA, et al. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. European Heart Journal. Acute Cardiovascular Care. PMID 27485140 DOI: 10.1177/2048872616661692  0.428
2016 Cavender MA, Bhatt DL, Stone GW, White HD, Steg PG, Gibson CM, Hamm CW, Price MJ, Leonardi S, Prats J, Deliargyris EN, Mahaffey KW, Harrington RA. Consistent Reduction in Peri-Procedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX. Circulation. PMID 27482008 DOI: 10.1161/CIRCULATIONAHA.115.020829  0.397
2016 Yu J, Baber U, Mastoris I, Dangas G, Sartori S, Steg PG, Cohen DJ, Giustino G, Chandrasekhar J, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, et al. Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. Jacc. Cardiovascular Interventions. 9: 1461-9. PMID 27478113 DOI: 10.1016/j.jcin.2016.04.004  0.316
2016 Daaboul Y, Korjian S, Weaver WD, Kloner RA, Giugliano RP, Carr J, Neal BJ, Chi G, Cochet M, Goodell L, Michalak N, Rusowicz-Orazem L, Alkathery T, Allaham H, Routray S, ... ... Gibson CM, et al. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). The American Journal of Cardiology. PMID 27392509 DOI: 10.1016/j.amjcard.2016.06.025  0.373
2016 Baber U, Dangas G, Chandrasekhar J, Sartori S, Steg PG, Cohen DJ, Giustino G, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, Chieffo A, Moliterno DJ, et al. Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. Jacc. Cardiovascular Interventions. 9: 1349-57. PMID 27388822 DOI: 10.1016/j.jcin.2016.04.009  0.37
2016 Vaduganathan M, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL. Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial. Circulation. Cardiovascular Interventions. 9. PMID 27313282 DOI: 10.1161/CIRCINTERVENTIONS.116.003612  0.316
2016 Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, et al. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. Journal of the American College of Cardiology. PMID 27079334 DOI: 10.1016/j.jacc.2016.02.064  0.352
2016 Povsic TJ, Roe MT, Ohman EM, Steg PG, James S, Plotnikov A, Mundl H, Welsh R, Bode C, Gibson CM. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. American Heart Journal. 174: 120-8. PMID 26995378 DOI: 10.1016/j.ahj.2016.01.004  0.389
2016 Little RJ, Wang J, Sun X, Tian H, Suh EY, Lee M, Sarich T, Oppenheimer L, Plotnikov A, Wittes J, Cook-Bruns N, Burton P, Gibson CM, Mohanty S. The treatment of missing data in a large cardiovascular clinical outcomes study. Clinical Trials (London, England). PMID 26908543 DOI: 10.1177/1740774515626411  0.31
2016 Pokorney SD, Radder C, Schulte PJ, Al-Khatib SM, Tricocci P, Van de Werf F, James SK, Cannon CP, Armstrong PW, White HD, Califf RM, Gibson CM, Giugliano RP, Wallentin L, Mahaffey KW, et al. High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction. American Heart Journal. 171: 25-32. PMID 26699597 DOI: 10.1016/J.Ahj.2015.09.004  0.352
2016 Daaboul Y, Korjian S, Weaver WD, Kloner R, Giugliano R, Carr J, Neal BJ, Chi G, Cochet M, Goodell L, Michalak N, Rusowicz-Orazem L, Alkathery T, Allaham H, Shakil M, ... ... Gibson CM, et al. THE ASSOCIATION BETWEEN LEFT VENTRICULAR MASS AND MEASURES OF INFARCT SIZE IN ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE EMBRACE STEMI CLINICAL TRIAL Journal of the American College of Cardiology. 67: 495. DOI: 10.1016/S0735-1097(16)30496-X  0.348
2015 Gibson CM, Giugliano RP, Kloner RA, Bode C, Tendera M, Jánosi A, Merkely B, Godlewski J, Halaby R, Korjian S, Daaboul Y, Chakrabarti AK, Spielman K, Neal BJ, Weaver WD. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention. European Heart Journal. PMID 26586786 DOI: 10.1093/Eurheartj/Ehv597  0.354
2015 Rao SV, Zeymer U, Douglas PS, Al-Khalidi H, Liu J, Gibson CM, Harrison RW, Joseph DS, Heyrman R, Krucoff MW. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial. American Heart Journal. 170: 929-37. PMID 26542501 DOI: 10.1016/j.ahj.2015.08.017  0.39
2015 Angiolillo DJ, Bhatt DL, Steg PG, Stone GW, White HD, Gibson CM, Hamm CW, Price MJ, Prats J, Liu T, Mahaffey KW, Harrington RA. Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials. Journal of Thrombosis and Thrombolysis. PMID 26024789 DOI: 10.1007/s11239-015-1233-3  0.322
2015 Ghobrial J, Gibson CM, Pinto DS. Delayed clopidogrel transit during myocardial infarction evident on angiography. The Journal of Invasive Cardiology. 27: E68-9. PMID 25929306  0.355
2015 Gibson CM, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P, van Eickels M, Lip GY, Cohen M, Husted S, Peterson E, Fox K. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). American Heart Journal. 169: 472-8.e5. PMID 25819853 DOI: 10.1016/J.Ahj.2014.12.006  0.335
2015 Kobayashi N, Maehara A, Mintz GS, Wolff SD, Généreux P, Xu K, Mehran R, Gibson CM, Brener SJ, Stone GW. Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy). The American Journal of Cardiology. 115: 1389-95. PMID 25770973 DOI: 10.1016/j.amjcard.2015.02.034  0.399
2015 White HD, Bhatt DL, Gibson CM, Hamm CW, Mahaffey KW, Price MJ, Steg PG, Stone GW, Cortese B, Wilensky M, Deliargyris EN, Liu T, Prats J, Harrington RA. Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]). Jacc. Cardiovascular Interventions. 8: 424-33. PMID 25703887 DOI: 10.1016/j.jcin.2014.09.025  0.383
2015 De Luca G, Van't Hof AW, Gibson CM, Cutlip D, Zeymer U, Noc M, Maioli M, Zorman S, Gabriel HM, Emre A, Rakowski T, Gyongyosi M, Huber K, Bellandi F, Dudek D, et al. Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). The American Journal of Cardiology. 115: 711-5. PMID 25655867 DOI: 10.1016/j.amjcard.2014.12.030  0.366
2015 Dohi T, Maehara A, Brener SJ, Généreux P, Gershlick AH, Mehran R, Gibson CM, Mintz GS, Stone GW. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). The American Journal of Cardiology. 115: 563-70. PMID 25586335 DOI: 10.1016/j.amjcard.2014.12.008  0.386
2015 Tomey MI, Mehran R, Brener SJ, Maehara A, Witzenbichler B, Dizon JM, El-Omar M, Xu K, Gibson CM, Stone GW. Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI). American Heart Journal. 169: 86-93. PMID 25497252 DOI: 10.1016/j.ahj.2014.06.019  0.36
2015 Celik T, Kaya MG, Akpek M, Gunebakmaz O, Balta S, Sarli B, Duran M, Demirkol S, Uysal OK, Oguzhan A, Gibson CM. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology. 66: 155-62. PMID 24301422 DOI: 10.1177/0003319713513493  0.401
2015 Sherwood M, Lopes R, Sun J, Harrington R, Wallentin L, Laskowitz DT, James S, Goodman S, Darius H, Lewis B, Liaw D, Gibson CM, Alexander J. APIXABAN FOLLOWING ACUTE CORONARY SYNDROMES AMONG PATIENTS WITH PRIOR STROKE: INSIGHTS FROM THE APPRAISE-2 TRIAL Journal of the American College of Cardiology. 65: A195. DOI: 10.1016/S0735-1097(15)60195-4  0.336
2015 Aragon JR, Korjian S, Halaby R, Daaboul Y, Shenoda M, Price S, Bacon J, Beckord B, Miller J, Florea A, Spielman K, Cochet M, Stepanchak M, Gibson CM. INTRACORONARY BIVALIRUDIN ADMINISTRATION IN STEMI IMPROVES CORONARY FLOW Journal of the American College of Cardiology. 65: A121. DOI: 10.1016/S0735-1097(15)60121-8  0.315
2015 Giustino G, Brener S, Maehara A, Mehran R, Genereux P, Dudek D, Neunteufl T, Metzger DC, Ozan M, Gibson CM, Stone GW. TCT-265 Impact of Platelet Count on Myocardial Infarct Size and Adverse Events in Anterior ST-Elevation Myocardial Infarction: Results from the INFUSE-AMI Trial Journal of the American College of Cardiology. 66: B104-B105. DOI: 10.1016/J.JACC.2015.08.948  0.388
2015 Giustino G, Brener S, Maehara A, Genereux P, Mehran R, Dudek D, Neunteufl T, Metzger DC, Ozan M, Gibson CM, Stone GW. TCT-238 Impact of Smoking on Infarct Size and Adverse Events in Patients With Anterior ST-Elevation Myocardial Infarction: Results From the INFUSE-AMI Trial Journal of the American College of Cardiology. 66: B92-B93. DOI: 10.1016/J.JACC.2015.08.921  0.367
2015 Daaboul Y, Halaby R, Korjian S, Bahaa Eldin H, Lemor A, Singh K, Susheela AT, Ponnusamy V, Beereddy D, Hernández-Elenes JR, Poongkunran M, Ajari OW, Alvarado A, Gibson CM. Dual Pathway Therapy for Secondary Prevention Following Acute Coronary Syndrome Current Cardiovascular Risk Reports. 9. DOI: 10.1007/s12170-014-0432-3  0.34
2014 Cavender MA, Gibson CM, Braunwald E, Wiviott SD, Murphy SA, Toda Kato E, Plotnikov AN, Amuchástegui M, Oude Ophuis T, van Hessen M, Mega JL. The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial. European Heart Journal. Acute Cardiovascular Care. PMID 25318481 DOI: 10.1177/2048872614554109  0.433
2014 Gibson CM, Krucoff M, Kirtane AJ, Rao SV, Mackall JA, Matthews R, Saba S, Waksman R, Holmes D. Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. American Heart Journal. 168: 424-429.e1. PMID 25262250 DOI: 10.1016/j.ahj.2014.05.010  0.405
2014 Harrington RA, Popma CJ, Gibson CM. Advances in understanding percutaneous coronary intervention pharmacology: ischemia, bleeding, the ISAR research group, and a commitment to progress. Coronary Artery Disease. 25: 453-5. PMID 25072657 DOI: 10.1097/MCA.0000000000000137  0.307
2014 Guerchicoff A, Brener SJ, Maehara A, Witzenbichler B, Fahy M, Xu K, Gersh BJ, Mehran R, Gibson CM, Stone GW. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction). Jacc. Cardiovascular Interventions. 7: 733-40. PMID 25060015 DOI: 10.1016/j.jcin.2014.01.166  0.438
2014 Brener SJ, Oldroyd KG, Maehara A, El-Omar M, Witzenbichler B, Xu K, Mehran R, Gibson CM, Stone GW. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). The American Journal of Cardiology. 113: 1457-60. PMID 24630789 DOI: 10.1016/j.amjcard.2014.02.002  0.434
2014 Kunadian V, Giugliano RP, Newby LK, Zorkun C, Guo J, Bagai A, Montalescot G, Braunwald E, Califf RM, Van de Werf F, Armstrong PW, Harrington R, Gibson CM. Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial). The American Journal of Cardiology. 113: 1297-305. PMID 24607027 DOI: 10.1016/J.Amjcard.2014.01.404  0.44
2014 Dizon JM, Brener SJ, Maehara A, Witzenbichler B, Biviano A, Godlewski J, Parise H, Dambrink JH, Mehran R, Gibson CM, Stone GW. Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial. European Heart Journal. Acute Cardiovascular Care. 3: 78-83. PMID 24562806 DOI: 10.1177/2048872613508658  0.41
2014 De Ferrari GM, Fox KA, White JA, Giugliano RP, Tricoci P, Reynolds HR, Hochman JS, Gibson CM, Théroux P, Harrington RA, Van de Werf F, White HD, Califf RM, Newby LK. Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. European Heart Journal. Acute Cardiovascular Care. 3: 37-45. PMID 24562802 DOI: 10.1177/2048872613489315  0.394
2014 Brener SJ, Dambrink JH, Maehara A, Chowdhary S, Gershlick AH, Genereux P, Koolen J, Mehran R, Fahy M, Gibson CM, Stone GW. Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 9: 1195-201. PMID 24561570 DOI: 10.4244/EIJV9I10A201  0.437
2014 Rhee JW, Wiviott SD, Scirica BM, Gibson CM, Murphy SA, Bonaca MP, Morrow DA, Mega JL. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clinical Cardiology. 37: 350-6. PMID 24481910 DOI: 10.1002/clc.22253  0.332
2014 Waks JW, Sabatine MS, Cannon CP, Morrow DA, Gibson CM, Wiviott SD, Giugliano RP, Sloan S, Scirica BM. Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial. Clinical Cardiology. 37: 160-6. PMID 24452727 DOI: 10.1002/clc.22235  0.351
2014 Généreux P, Stone GW, Harrington RA, Gibson CM, Steg PG, Brener SJ, Angiolillo DJ, Price MJ, Prats J, Lasalle L, Liu T, Todd M, Skerjanec S, Hamm CW, Mahaffey KW, et al. Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention). Journal of the American College of Cardiology. 63: 619-29. PMID 24184169 DOI: 10.1016/j.jacc.2013.10.022  0.343
2014 Sanidas EA, Brener SJ, Maehara A, Généreux P, Witzenbichler B, El-Omar M, Fahy M, Mehran R, Gibson CM, Stone GW. Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 83: 704-10. PMID 24030863 DOI: 10.1002/ccd.25203  0.417
2014 De Luca G, van't Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Secco GG, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, et al. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. Heart and Vessels. 29: 15-20. PMID 23494604 DOI: 10.1007/s00380-013-0323-4  0.395
2014 Celik T, Kaya MG, Akpek M, Yarlioglues M, Sarli B, Topsakal R, Gibson CM. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI. Angiology. 65: 198-204. PMID 23378197 DOI: 10.1177/0003319712474948  0.379
2014 Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM. RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Rational Pharmacotherapy in Cardiology. 10: 245-252. DOI: 10.20996/1819-6446-2014-10-2-245-252  0.386
2014 Baber U, Schoos M, Sartori S, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Kini A, Stuckey T, Cohen DJ, Berger PB, Dangas G, Waksman R, Antoniucci D, ... ... Gibson CM, et al. TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY Journal of the American College of Cardiology. 63: A1725. DOI: 10.1016/S0735-1097(14)61728-9  0.344
2013 Kaul P, Tanguay JF, Newby LK, Hochman JS, Westerhout CM, Califf RM, Tricoci P, Gibson CM, Giugliano RP, Harrington RA, Van de Werf F, Armstrong PW. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial. American Heart Journal. 166: 723-8. PMID 24093853 DOI: 10.1016/j.ahj.2013.07.014  0.372
2013 Stone GW, Witzenbichler B, Godlewski J, Dambrink JH, Ochala A, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Dizon JM, Wolff SD, Brener SJ, Mehran R, Maehara A, Gibson CM. Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial. Circulation. Cardiovascular Interventions. 6: 527-34. PMID 24084626 DOI: 10.1161/CIRCINTERVENTIONS.113.000644  0.465
2013 Palmerini T, Brener SJ, Genereux P, Maehara A, Della Riva D, Mariani A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Fahy M, Xu K, Gibson CM, Stone GW. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). The American Journal of Cardiology. 112: 1860-6. PMID 24063843 DOI: 10.1016/j.amjcard.2013.08.010  0.452
2013 Patrick WL, Patel C, Guddeti R, Narayan A, Maddaleni M, Kumar S, Dolma K, Serla VV, Sangha M, Govindavarjhulla A, Saddala P, Singh P, Halaby R, Gibson CM. Is there a need for "triple therapy"? Role of anticoagulation with dual antiplatelet therapy in acute coronary syndromes (ATLAS Study & TRAP Study). Current Cardiology Reports. 15: 411. PMID 24022544 DOI: 10.1007/s11886-013-0411-1  0.352
2013 Bagai A, White JA, Lokhnygina Y, Giugliano RP, Van de Werf F, Montalescot G, Armstrong PW, Tricoci P, Gibson CM, Califf RM, Harrington RA, Newby LK. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial. American Heart Journal. 166: 466-73. PMID 24016495 DOI: 10.1016/J.Ahj.2013.05.019  0.433
2013 Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet. 382: 1981-92. PMID 24011551 DOI: 10.1016/S0140-6736(13)61615-3  0.451
2013 Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Berger PB, Iakovou I, Dangas G, Waksman R, Antoniucci D, ... ... Gibson CM, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 382: 1714-22. PMID 24004642 DOI: 10.1016/S0140-6736(13)61720-1  0.343
2013 De Luca G, van't Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, et al. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty. The American Journal of Cardiology. 112: 1083-6. PMID 23910428 DOI: 10.1016/j.amjcard.2013.05.053  0.364
2013 Brener SJ, Maehara A, Dizon JM, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink JH, Mehran R, Oldroyd K, Gibson CM, Stone GW. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Jacc. Cardiovascular Interventions. 6: 718-24. PMID 23866184 DOI: 10.1016/j.jcin.2013.03.013  0.394
2013 Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Califf RM, Harrington RA, Newby LK, Pollack CV, Montalescot G, Van de Werf F, Gibson CM, Giugliano RP. Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”. Circulation. 127: e634. PMID 23833786 DOI: 10.1161/Circulationaha.112.147546  0.352
2013 Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. American Heart Journal. 166: 64-70. PMID 23816023 DOI: 10.1016/j.ahj.2013.03.029  0.399
2013 Brener SJ, Dambrink JH, Maehara A, Chowdhary S, Gershlick AH, Genereux P, Koolen J, Mehran R, Fahy M, Gibson CM, Stone GW. Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. PMID 23764966  0.399
2013 Mega JL, Braunwald E, Wiviott SD, Murphy SA, Plotnikov A, Gotcheva N, Ruda M, Gibson CM. Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51). The American Journal of Cardiology. 112: 472-8. PMID 23711804 DOI: 10.1016/J.Amjcard.2013.04.011  0.37
2013 Tricoci P, Leonardi S, White J, White HD, Armstrong PW, Montalescot G, Giugliano RP, Gibson CM, Van de Werf F, Califf RM, Harrington RA, Braunwald E, Mahaffey KW, Newby LK. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. Journal of the American College of Cardiology. 62: 242-51. PMID 23684676 DOI: 10.1016/J.Jacc.2013.04.043  0.426
2013 Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. Journal of the American College of Cardiology. 62: 286-90. PMID 23602776 DOI: 10.1016/J.Jacc.2013.03.041  0.417
2013 Buyukkaya E, Poyraz F, Karakas MF, Kurt M, Akcay AB, Akpinar I, Motor S, Turak O, Ozturk OH, Sen N, Akpek M, Kaya MG, Gibson CM. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The American Journal of Cardiology. 112: 187-93. PMID 23601576 DOI: 10.1016/j.amjcard.2013.03.011  0.417
2013 Williams JB, Lopes RD, Hafley GE, Ferguson TB, Mack MJ, Gibson CM, Harrington RA, Peterson ED, Smith PK, Mehta RH, Alexander JH. Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting. Journal of Thrombosis and Thrombolysis. 36: 384-93. PMID 23543398 DOI: 10.1007/s11239-013-0904-1  0.379
2013 Klutstein MW, Westerhout CM, Armstrong PW, Giugliano RP, Lewis BS, Gibson CM, Lutchmedial S, Widimsky P, Steg PG, Dalby A, Zeymer U, Van de Werf F, Harrington RA, Newby LK, Rao SV. Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy. American Heart Journal. 165: 583-590.e1. PMID 23537976 DOI: 10.1016/j.ahj.2013.01.009  0.399
2013 Chakrabarti AK, Feeney K, Abueg C, Brown DA, Czyz E, Tendera M, Janosi A, Giugliano RP, Kloner RA, Weaver WD, Bode C, Godlewski J, Merkely B, Gibson CM. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. American Heart Journal. 165: 509-514.e7. PMID 23537966 DOI: 10.1016/J.Ahj.2012.12.008  0.445
2013 Goel K, Pinto DS, Gibson CM. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review. American Heart Journal. 165: 451-67. PMID 23537961 DOI: 10.1016/j.ahj.2012.11.014  0.31
2013 Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). Journal of the American College of Cardiology. 61: 1853-9. PMID 23500262 DOI: 10.1016/J.Jacc.2013.01.066  0.434
2013 Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimský P, Tousek F, Tauth J, Spriggs D, et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. The New England Journal of Medicine. 368: 1303-13. PMID 23473369 DOI: 10.1056/NEJMoa1300815  0.343
2013 Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, et al. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial. Coronary Artery Disease. 24: 321-7. PMID 23442944 DOI: 10.1097/Mca.0B013E32835F2Fbd  0.406
2013 Pride YB, Piccirillo BJ, Gibson CM. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. The American Journal of Cardiology. 111: 914-8. PMID 23276472 DOI: 10.1016/j.amjcard.2012.11.042  0.341
2013 Nazer B, Ray KK, Murphy SA, Gibson CM, Cannon CP. Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy. Journal of Thrombosis and Thrombolysis. 36: 233-9. PMID 23212806 DOI: 10.1007/s11239-012-0853-0  0.407
2013 Lopes RD, White JA, Tricoci P, White HD, Armstrong PW, Braunwald E, Giugliano RP, Harrington RA, Lewis BS, Brogan GX, Gibson CM, Califf RM, Newby LK. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. International Journal of Cardiology. 167: 2580-7. PMID 22795720 DOI: 10.1016/J.Ijcard.2012.06.053  0.376
2013 Kaya M, Akpek M, Celik T, Gibson CM. PROGNOSTIC VALUE OF NEUTROPHIL/LYMPHOCYTE RATIO IN PATIENTS WITH STEMI UNDERGOING PRIMARY CORONARY INTERVENTION: TEN-YEAR FOLLOW-UP RESULTS OF MULTICENTER EXPERIENCES Journal of the American College of Cardiology. 61: E163. DOI: 10.1016/S0735-1097(13)60164-3  0.329
2013 Cavender M, Braunwald E, Gibson CM, Wiviott S, Murphy S, Amuchastegui M, Ophuis AO, van Hessen M, Mega J. RIVAROXABAN REDUCES SPONTANEOUS AND LARGE MYOCARDIAL INFARCTIONS: FINDINGS FROM THE ATLAS ACS 2 – TIMI 51 TRIAL Journal of the American College of Cardiology. 61: E3. DOI: 10.1016/S0735-1097(13)60004-2  0.371
2013 Guerchicoff A, Brener S, Fahy M, Gibson CM, Maehara A, Mehran R, Stone G, Witzenbichler B. TCT-230 Impact of Delay to reperfusion on Infarct Size and Clinical Outcomes in Patients with STEMI: The INFUSE-AMI Trial Journal of the American College of Cardiology. 62: B75. DOI: 10.1016/J.JACC.2013.08.965  0.329
2013 Sanidas E, Brener S, Maehara A, Genereux P, Witzenbichler B, El-Omar M, Xu K, Fahy M, Mehran R, Gibson CM, Stone GW. TCT-222 Reperfusion Success, Infarct Size and Clinical Outcomes in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Anterior Myocardial Infarction Journal of the American College of Cardiology. 62: B72. DOI: 10.1016/J.JACC.2013.08.957  0.433
2012 Chakrabarti AK, Patel SJ, Salazar RL, Gopalakrishnan L, Kumar V, Rastogi U, Singh P, Zorkun C, Gibson CM. Newer Pharmaceutical Agents for STEMI Interventions. Interventional Cardiology Clinics. 1: 429-440. PMID 28581961 DOI: 10.1016/j.iccl.2012.06.005  0.344
2012 Chakrabarti AK, Gibson CM, Pinto DS. Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy. Current Opinion in Cardiology. 27: 651-4. PMID 23032713 DOI: 10.1097/HCO.0b013e3283587c69  0.405
2012 Pride YB, Mohanavelu S, Zorkun C, Kunadian V, Giugliano RP, Newby LK, Braunwald E, Califf RM, Harrington RA, Gibson CM. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy. Jacc. Cardiovascular Interventions. 5: 927-35. PMID 22995880 DOI: 10.1016/J.Jcin.2012.05.007  0.431
2012 De Luca G, Gibson CM, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz HR, Maioli M, Secco GG, Zorman S, Gabriel HM, Emre A, et al. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 8: 470-6. PMID 22917731 DOI: 10.4244/EIJV8I4A74  0.308
2012 Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, Wang W, Gibson CM. Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics. Cardiology Research and Practice. 2012: 704314. PMID 22830071 DOI: 10.1155/2012/704314  0.305
2012 Welsh RC, Rao SV, Zeymer U, Thompson VP, Huber K, Kochman J, McClure MW, Gretler DD, Bhatt DL, Gibson CM, Angiolillo DJ, Gurbel PA, Berdan LG, Paynter G, Leonardi S, et al. A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial. Circulation. Cardiovascular Interventions. 5: 336-46. PMID 22647518 DOI: 10.1161/CIRCINTERVENTIONS.111.964197  0.331
2012 Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Pollack CV, Montalescot G, Van de Werf F, Gibson CM, Giugliano RP, Califf RM, Harrington RA, Newby LK. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 126: 41-9. PMID 22645292 DOI: 10.1161/Circulationaha.111.071860  0.362
2012 Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. The American Journal of Cardiology. 110: 621-7. PMID 22608360 DOI: 10.1016/j.amjcard.2012.04.041  0.435
2012 Gopalakrishnan L, Kumar V, Kohli P, Singh P, Rastogi U, Gibson CM. Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes. Expert Opinion On Drug Metabolism & Toxicology. 8: 889-900. PMID 22577900 DOI: 10.1517/17425255.2012.688026  0.353
2012 Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Carlton TW, Cristea E, Wolff SD, Brener SJ, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, ... ... Gibson CM, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. Jama. 307: 1817-26. PMID 22447888 DOI: 10.1001/jama.2012.421  0.452
2012 Wu Y, Wu H, Mueller C, Gibson CM, Murphy S, Shi Y, Xu G, Yang J. Baseline platelet count and clinical outcome in acute coronary syndrome. Circulation Journal : Official Journal of the Japanese Circulation Society. 76: 704-11. PMID 22277319 DOI: 10.1253/circj.CJ-11-0707  0.34
2012 Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin O, Cosgun SM, Oguzhan A, Eren M, Gibson CM. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. The American Journal of Cardiology. 109: 486-91. PMID 22100027 DOI: 10.1016/j.amjcard.2011.09.042  0.398
2012 Kırma C, Erkol A, Pala S, Oduncu V, Dündar C, Ä°zgi A, Tigen K, Gibson CM. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 79: 59-67. PMID 21523892 DOI: 10.1002/ccd.23109  0.447
2012 Kunadian V, Gibson CM. Thrombolytics and myocardial infarction. Cardiovascular Therapeutics. 30: e81-8. PMID 21070617 DOI: 10.1111/j.1755-5922.2010.00239.x  0.449
2012 Palmerini T, Brener S, Dambrink J, Fahy M, Gibson CM, Godlewski J, Maehara A, Ochala A, Parise H, Stone G, Witzenbichler B. TCT-486 Relationship Between White Blood Cell Count and Final Infarct Size in Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis from the INFUSE-AMI Trial Journal of the American College of Cardiology. 60: B140. DOI: 10.1016/J.JACC.2012.08.518  0.441
2012 Brener S, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink J, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone G. TCT-467 Clinical Outcomes after Anterior ST-Elevation Myocardial Infarction According to LAD Lesion Location: The INFUSE-AMI Trial Journal of the American College of Cardiology. 60: B135. DOI: 10.1016/J.JACC.2012.08.499  0.346
2012 Gukathasan N, Mehran R, Brener S, Maehara A, Sergie Z, Metzger DC, Oldroyd K, Parise H, Fahy M, Gibson CM, Stone G. TCT-366 Impact of gender on adverse cardiac events in patients with large anterior myocardial infarction: Results from the INFUSE-AMI trial Journal of the American College of Cardiology. 60: B105. DOI: 10.1016/J.JACC.2012.08.393  0.385
2012 Baber U, Mehran R, Brener S, Maehara A, Dudek D, Neunteufl T, Metzger DC, Gibson CM, Stone G. TCT-149 Impact of Chronic Kidney Disease on Myocardial Infarct Size and Adverse Events in ST-Elevation Myocardial Infarction: Results from the INFUSE-AMI Trial Journal of the American College of Cardiology. 60: B43. DOI: 10.1016/J.JACC.2012.08.168  0.368
2012 Maehara A, Mintz G, Brener S, Dambrink J, El-Omar M, Gershlick A, Fahy M, Mehran R, Gibson CM, Stone G. TCT-59 Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy Journal of the American College of Cardiology. 60: B19. DOI: 10.1016/J.JACC.2012.08.070  0.346
2012 Dambrink J, Brener S, Maehara A, Chowdhary S, Gershlick A, Koolen J, Mehran R, Fahy M, Gibson CM, Stone G. TCT-58 Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial Journal of the American College of Cardiology. 60: B18. DOI: 10.1016/J.JACC.2012.08.069  0.386
2012 Stone GW, Brener SJ, Gibson CM. Abciximab vs Thrombectomy for Reperfusion in Myocardial Infarction—Reply Jama. 308: 565. DOI: 10.1001/JAMA.2012.8167  0.351
2011 Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV, Ornato JP, Zalenski RJ, Penney J, Tiefenbrunn AJ, Greenland P. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. Jama. 306: 2120-7. PMID 22089719 DOI: 10.1001/Jama.2011.1654  0.35
2011 Pinto DS, Frederick PD, Chakrabarti AK, Kirtane AJ, Ullman E, Dejam A, Miller DP, Henry TD, Gibson CM. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 124: 2512-21. PMID 22064592 DOI: 10.1161/CIRCULATIONAHA.111.018549  0.407
2011 Akpek M, Kaya MG, Uyarel H, Yarlioglues M, Kalay N, Gunebakmaz O, Dogdu O, Ardic I, Elcik D, Sahin O, Oguzhan A, Ergin A, Gibson CM. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 219: 334-41. PMID 21831375 DOI: 10.1016/j.atherosclerosis.2011.07.021  0.312
2011 Navarese EP, De Luca G, Castriota F, Kozinski M, Gurbel PA, Gibson CM, Andreotti F, Buffon A, Siller-Matula JM, Sukiennik A, De Servi S, Kubica J. Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. Journal of Thrombosis and Haemostasis : Jth. 9: 1902-15. PMID 21777368 DOI: 10.1111/j.1538-7836.2011.04445.x  0.386
2011 Pride YB, Gibson CM. Percutaneous coronary interventions in facilities without cardiac surgery on site. Current Cardiology Reports. 13: 432-8. PMID 21750909 DOI: 10.1007/s11886-011-0197-y  0.303
2011 Wu J, Pride YB, Frederick PD, Gibson CM. Association of initial thrombolysis in myocardial infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a National Registry of Myocardial Infarction-5 (NRMI-5) analysis. American Heart Journal. 162: 178-83. PMID 21742106 DOI: 10.1016/j.ahj.2011.03.018  0.451
2011 Kunadian V, Pride YB, Buros JL, Ciaglo LN, Morrow DA, Gibson CM. Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: a PROTECT TIMI-30 analysis. Journal of Thrombosis and Thrombolysis. 32: 448-52. PMID 21713377 DOI: 10.1007/s11239-011-0617-2  0.414
2011 Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 123: 2736-47. PMID 21670242 DOI: 10.1161/Circulationaha.110.009449  0.417
2011 Cicek G, Uyarel H, Ergelen M, Ayhan E, Abanonu GB, Eren M, Gibson CM. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction Coronary Artery Disease. 22: 131-137. PMID 21394027 DOI: 10.1097/MCA.0b013e328342c760  0.446
2011 Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, Cox D, Grines C, Dudek D, Steg G, Parise H, Wolff SD, Cristea E, Stone GW. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. American Heart Journal. 161: 478-486.e7. PMID 21392601 DOI: 10.1016/j.ahj.2010.10.006  0.453
2011 Navarese EP, De Servi S, Gibson CM, Buffon A, Castriota F, Kubica J, Petronio AS, Andreotti F, De Luca G. Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies. Qjm : Monthly Journal of the Association of Physicians. 104: 193-200. PMID 21262739 DOI: 10.1093/qjmed/hcq258  0.4
2011 Erkol A, Pala S, Kırma C, Oduncu V, Dündar C, Izgi A, Tigen K, Gibson CM. Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. The American Journal of Cardiology. 107: 857-62. PMID 21247537 DOI: 10.1016/j.amjcard.2010.10.071  0.332
2011 Uyarel H, Ergelen M, Cicek G, Kaya MG, Ayhan E, Turkkan C, Yıldırım E, Kırbas V, Onturk ET, Erer HB, Yesilcimen K, Gibson CM. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coronary Artery Disease. 22: 138-44. PMID 21233710 DOI: 10.1097/MCA.0b013e328342c77b  0.397
2011 De Luca G, Gibson CM, Gyöngyösi M, Zeymer U, Dudek D, Arntz HR, Bellandi F, Maioli M, Noc M, Zorman S, Gabriel HM, Emre A, Cutlip D, Rakowski T, Huber K, et al. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. Journal of Thrombosis and Thrombolysis. 30: 342-6. PMID 20213259 DOI: 10.1007/s11239-010-0451-y  0.356
2011 Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV, Ornato JP, Lambrew CG, Zalenski RJ, Penney J, Tiefenbrunn AJ, Greenland P. Risk Factors Ascertained At Presentation And Mortality Among Patients With First Myocardial Infarction Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)61037-1  0.325
2011 Akpek M, Kaya M, Uyarel H, Yarlioglues M, Gunebakmaz O, Elcik D, Sahin O, Dogdu O, Ardic I, Oguzhan A, Ergin A, Gibson C. OP-214: THE ASSOCIATION OF SERUM URIC ACID LEVELS WITH CORONARY FLOW IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI International Journal of Cardiology. 147: S88. DOI: 10.1016/S0167-5273(11)70253-4  0.312
2010 Becker RC, Gibson CM, Jennings LK, Morrow DA. Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions. The American Journal of Cardiology. 106: S2-3. PMID 20920638 DOI: 10.1016/J.Amjcard.2010.08.026  0.368
2010 Fischell TA, Fischell DR, Avezum A, John MS, Holmes D, Foster M, Kovach R, Medeiros P, Piegas L, Guimaraes H, Gibson CM. Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemia. Journal of the American College of Cardiology. 56: 1089-98. PMID 20863952 DOI: 10.1016/j.jacc.2010.04.053  0.349
2010 Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, Giugliano R, Braunwald E, Gibson CM. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. Jacc. Cardiovascular Interventions. 3: 806-11. PMID 20723851 DOI: 10.1016/J.Jcin.2010.05.012  0.389
2010 Pride YB, Giuseffi JL, Mohanavelu S, Harrigan CJ, Manning WJ, Gibson CM, Appelbaum E. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct American Journal of Cardiology. 106: 635-640. PMID 20723637 DOI: 10.1016/j.amjcard.2010.04.012  0.368
2010 Leonardi S, Rao SV, Harrington RA, Bhatt DL, Gibson CM, Roe MT, Kochman J, Huber K, Zeymer U, Madan M, Gretler DD, McClure MW, Paynter GE, Thompson V, Welsh RC. Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI). American Heart Journal. 160: 65-72. PMID 20598974 DOI: 10.1016/j.ahj.2010.04.008  0.356
2010 Sherwood MW, Morrow DA, Scirica BM, Jiang S, Bode C, Rifai N, Gerszten RE, Gibson CM, Cannon CP, Braunwald E, Sabatine MS. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28. American Heart Journal. 159: 964-971.e1. PMID 20569707 DOI: 10.1016/J.Ahj.2010.03.005  0.372
2010 Giugliano RP, Giraldez RR, Morrow DA, Antman EM, Gibson CM, Mohanavelu S, Murphy SA, McCabe CH, Braunwald E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. European Heart Journal. 31: 2103-10. PMID 20413397 DOI: 10.1093/Eurheartj/Ehq100  0.406
2010 Hudson M, Greenbaum A, Brenton L, Gibson CM, Siegel R, Reeves LR, Sala MF, McKendall G, Bluguermann J, Echt D, Ohman EM, Weaver WD. Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial. Jacc. Cardiovascular Interventions. 3: 352-9. PMID 20298997 DOI: 10.1016/j.jcin.2009.11.020  0.415
2010 Gibson CM, Pride YB. Myocardial Infarct Size Reduction With Pexelizumab. The Role of Chance Is Patently Clear Jacc: Cardiovascular Imaging. 3: 61-63. PMID 20129532 DOI: 10.1016/j.jcmg.2009.10.006  0.308
2010 Deibele AJ, Jennings LK, Tcheng JE, Neva C, Earhart AD, Gibson CM. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial. Circulation. 121: 784-91. PMID 20124127 DOI: 10.1161/Circulationaha.109.882746  0.388
2010 De Luca G, Gibson CM, Bellandi F, Noc M, Maioli M, Zorman S, Zeymer U, Gabriel HM, Emre A, Cutlip D, Arntz HR, Dudek D, Rakowski T, Gyongyosi M, Huber K, et al. Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. Journal of Thrombosis and Thrombolysis. 30: 23-8. PMID 19921103 DOI: 10.1007/s11239-009-0419-y  0.342
2010 Tanguay J, Newby LK, Hochman J, Westerhout CM, Califf RM, Gibson CM, Giugliano RP, Harrington RA, Van de Werf F, Armstrong PW. SEX DIFFERENCES IN HIGH-RISK ACUTE CORONARY SYNDROMES: INSIGHTS FROM EARLY-ACS Journal of the American College of Cardiology. 55: A120.E1122. DOI: 10.1016/S0735-1097(10)61123-0  0.311
2009 Pride YB, Canto JG, Frederick PD, Gibson CM. Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Circulation. Cardiovascular Quality and Outcomes. 2: 574-82. PMID 20031895 DOI: 10.1161/CIRCOUTCOMES.108.841296  0.362
2009 Gibson CM, Pride YB, Hochberg CP, Sloan S, Sabatine MS, Cannon CP. Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy Journal of the American College of Cardiology. 54: 2290-2295. PMID 19958964 DOI: 10.1016/j.jacc.2009.09.010  0.404
2009 Berger JS, Roe MT, Gibson CM, Kilaru R, Green CL, Melton L, Blankenship JD, Metzger DC, Granger CB, Gretler DD, Grines CL, Huber K, Zeymer U, Buszman P, Harrington RA, et al. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial. American Heart Journal. 158: 998-1004.e1. PMID 19958867 DOI: 10.1016/j.ahj.2009.10.010  0.436
2009 Pride YB, Canto JG, Frederick PD, Gibson CM. Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Jacc. Cardiovascular Interventions. 2: 944-52. PMID 19850253 DOI: 10.1016/j.jcin.2009.07.008  0.33
2009 Hoekstra JW, O'Neill BJ, Pride YB, Lefebvre C, Diercks DB, Peacock WF, Fermann GJ, Gibson CM, Pinto D, Giglio J, Chandra A, Cairns CB, Konstam MA, Massaro J, Krucoff M. Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial. Annals of Emergency Medicine. 54: 779-788.e1. PMID 19766352 DOI: 10.1016/J.Annemergmed.2009.06.525  0.368
2009 De Luca G, Gibson CM, Huber K, Zeymer U, Dudek D, Cutlip D, Bellandi F, Noc M, Emre A, Zorman S, Gabriel HM, Maioli M, Rakowski T, Gyöngyösi M, Van't Hof AW. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors. American Heart Journal. 158: 416-21. PMID 19699865 DOI: 10.1016/j.ahj.2009.06.029  0.378
2009 Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy. American Heart Journal. 158: e21-6. PMID 19699846 DOI: 10.1016/J.Ahj.2009.06.021  0.417
2009 Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction. The American Journal of Cardiology. 104: 475-9. PMID 19660597 DOI: 10.1016/j.amjcard.2009.04.005  0.378
2009 Gibson CM, Pride YB, Buros JL, Ciaglo LN, Morrow DA, Scirica BM, Stone PH. Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis). The American Journal of Cardiology. 104: 36-40. PMID 19576318 DOI: 10.1016/J.Amjcard.2009.02.044  0.451
2009 Appelbaum E, Abraham JM, Pride YB, Harrigan CJ, Peters DC, Biller LH, Manning WJ, Gibson CM. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction American Heart Journal. 158: 84-91. PMID 19540396 DOI: 10.1016/j.ahj.2009.04.012  0.341
2009 Hollander JE, Gibson CM, Pollack CV. Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes. The American Journal of Emergency Medicine. 27: 595-606. PMID 19497467 DOI: 10.1016/j.ajem.2008.04.019  0.36
2009 De Luca G, Gibson CM, Bellandi F, Noc M, Dudek D, Zeymer U, Arntz HR, Cutlip D, Maioli M, Zorman S, Mesquita Gabriel H, Emre A, Rakowski T, Gyongyosi M, Huber K, et al. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. Atherosclerosis. 207: 181-5. PMID 19426981 DOI: 10.1016/j.atherosclerosis.2009.03.042  0.33
2009 Frisch DR, Giedrimas E, Mohanavelu S, Shui A, Ho KKL, Gibson CM, Josephson ME, Zimetbaum PJ. Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction American Journal of Cardiology. 103: 1206-1209. PMID 19406260 DOI: 10.1016/j.amjcard.2009.01.028  0.395
2009 Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, Kleiman NS, Brindis RG, Peacock WF, Brener SJ, Menon V, Smith SC, Pollack CV, Gibler WB, Ohman EM, et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. European Heart Journal. 30: 1195-202. PMID 19339264 DOI: 10.1093/eurheartj/ehp099  0.324
2009 Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, Moliterno DJ, Van de Werf F, White HD, Harrington RA, Roe MT. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. American Heart Journal. 157: 716-23. PMID 19332201 DOI: 10.1016/j.ahj.2009.01.004  0.391
2009 Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial The Lancet. 373: 723-731. PMID 19249633 DOI: 10.1016/S0140-6736(09)60441-4  0.389
2009 Lakkis N, Tsyboulev V, Gibson CM, Murphy SA, Weintraub WS, DiBattiste PM, Cannon CP. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy. Critical Pathways in Cardiology. 1: 232-7. PMID 18340309 DOI: 10.1097/00132577-200212000-00005  0.395
2009 Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. Critical Pathways in Cardiology. 1: 44-52. PMID 18340288 DOI: 10.1097/00132577-200203000-00007  0.421
2009 Abraham JM, Gibson CM, Pena G, Sanz R, AlMahameed A, Murphy SA, Blanco J, Alonso-Briales J, Lopez-Mesa J, Gimeno F, Sánchez PL, Fernández-Avilés F. Association of angiographic perfusion score following percutaneous coronary intervention for ST-elevation myocardial infarction with left ventricular remodeling at 6 weeks in GRACIA-2. Journal of Thrombosis and Thrombolysis. 27: 253-8. PMID 18330516 DOI: 10.1007/S11239-008-0206-1  0.416
2009 Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM. Association of TIMI Myocardial Perfusion Grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction Journal of Thrombosis and Thrombolysis. 27: 123-129. PMID 18246410 DOI: 10.1007/s11239-008-0197-y  0.422
2008 Gibson CM. Antiplatelet therapy: Anti-ischemic benefits versus bleeding risk Journal of Interventional Cardiology. 21. PMID 19090934 DOI: 10.1111/j.1540-8183.2008.00407.x  0.424
2008 Peterson ED, Shah BR, Parsons L, Pollack CV, French WJ, Canto JG, Gibson CM, Rogers WJ. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal. 156: 1045-55. PMID 19032998 DOI: 10.1016/j.ahj.2008.07.028  0.367
2008 Gibson CM, Pride YB, Frederick PD, Pollack CV, Canto JG, Tiefenbrunn AJ, Weaver WD, Lambrew CT, French WJ, Peterson ED, Rogers WJ. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal. 156: 1035-44. PMID 19032997 DOI: 10.1016/j.ahj.2008.07.029  0.351
2008 Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack CV, Gore JM, Chandra-Strobos N, Peterson ED, French WJ. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal. 156: 1026-34. PMID 19032996 DOI: 10.1016/j.ahj.2008.07.030  0.363
2008 Kunadian V, Zorkun C, Williams SP, Biller LH, Palmer AM, Ogando KJ, Lew ME, Nethala N, Gibson WJ, Marble SJ, Buros JL, Gibson CM. Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction. Journal of Thrombosis and Thrombolysis. 26: 234-42. PMID 18818881 DOI: 10.1007/s11239-008-0276-0  0.323
2008 Yau JM, Alexander JH, Hafley G, Mahaffey KW, Mack MJ, Kouchoukos N, Goyal A, Peterson ED, Gibson CM, Califf RM, Harrington RA, Ferguson TB. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV). The American Journal of Cardiology. 102: 546-51. PMID 18721510 DOI: 10.1016/j.amjcard.2008.04.069  0.387
2008 Gibson CM, Zorkun C, Kunadian V. Intracoronary administration of abciximab in ST-elevation myocardial infarction. Circulation. 118: 6-8. PMID 18591449 DOI: 10.1161/CIRCULATIONAHA.108.780718  0.366
2008 Gibson CM, Pride YB, Buros JL, Kunadian V, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Braunwald E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy. The American Journal of Cardiology. 101: 1232-8. PMID 18435949 DOI: 10.1016/J.Amjcard.2007.12.023  0.424
2008 Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. American Heart Journal. 155: 654-60. PMID 18371472 DOI: 10.1016/j.ahj.2007.11.028  0.372
2008 O'Donoghue M, Morrow DA, Cannon CP, Guo W, Murphy SA, Gibson CM, Sabatine MS. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy European Heart Journal. 29: 984-991. PMID 18346960 DOI: 10.1093/eurheartj/ehn112  0.413
2008 Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 117: 886-96. PMID 18250271 DOI: 10.1161/Circulationaha.107.759167  0.39
2008 Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 51: 546-51. PMID 18237683 DOI: 10.1016/j.jacc.2007.08.061  0.344
2008 Magee MJ, Alexander JH, Hafley G, Ferguson TB, Gibson CM, Harrington RA, Peterson ED, Califf RM, Kouchoukos NT, Herbert MA, Mack MJ. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. The Annals of Thoracic Surgery. 85: 494-9; discussion 49. PMID 18222251 DOI: 10.1016/j.athoracsur.2007.10.008  0.325
2008 Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CM. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. International Journal of Cardiology. 131: 105-12. PMID 18187215 DOI: 10.1016/J.Ijcard.2007.09.006  0.31
2008 Pride YB, Buros JL, Lord E, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Gibson CM. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days. Journal of Thrombosis and Thrombolysis. 26: 106-12. PMID 17624497 DOI: 10.1007/s11239-007-0075-z  0.417
2008 Appelbaum E, Harrigan CJ, Kirtane AJ, Clark A, Manning WJ, Gibson CM. 1003 TIMI myocardial perfusion grade predicts infarct size, perimeter and border zone following STEMI Journal of Cardiovascular Magnetic Resonance. 10. DOI: 10.1186/1532-429X-10-S1-A128  0.306
2007 Yeh RW, Wiviott SD, Giugliano RP, Morrow DA, Shui A, Qin J, Scirica B, Bradner JE, Jang IK, Gibson CM, Antman EM. Effect of Thrombocytopenia on Outcomes Following Treatment With Either Enoxaparin or Unfractionated Heparin in Patients Presenting With Acute Coronary Syndromes American Journal of Cardiology. 100: 1734-1738. PMID 18082517 DOI: 10.1016/j.amjcard.2007.07.036  0.412
2007 Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. American Heart Journal. 155: 133-9. PMID 18082504 DOI: 10.1016/J.Ahj.2007.08.034  0.453
2007 Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM. Prasugrel versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine. 357: 2001-15. PMID 17982182 DOI: 10.1056/Nejmoa0706482  0.396
2007 Greenbaum AB, Ohman EM, Gibson CM, Borzak S, Stebbins AL, Lu M, Le May MR, Stankowski JE, Emanuelsson H, Weaver WD. Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial. American Heart Journal. 154: 702-9. PMID 17892995 DOI: 10.1016/j.ahj.2007.06.001  0.401
2007 Shah SR, Hochberg CP, Pinto DS, Gibson CM. Reperfusion strategies for ST-elevation myocardial infarction Current Cardiology Reports. 9: 281-288. PMID 17601394 DOI: 10.1007/BF02938376  0.44
2007 Murphy SA, Gibson CM, Morrow DA, Werf FVd, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. European Heart Journal. 28: 2077-2086. PMID 17600038 DOI: 10.1093/Eurheartj/Ehm224  0.419
2007 Gibson CM, Buros J, Ciaglo LN, Southard MC, Takao S, Harrigan C, Filopei J, Lew M, Marble SJ, Murphy SA, Cohen MG. Impact of Iodinated Contrast Injections on Percent Diameter Coronary Arterial Stenosis and Implications for Trials of Intracoronary Pharmacotherapies in Patients With ST-Elevation Myocardial Infarction American Journal of Cardiology. 100: 13-17. PMID 17599433 DOI: 10.1016/j.amjcard.2007.01.068  0.43
2007 Steinberg BA, Moghbeli N, Buros J, Ruda M, Parkhomenko A, Raju BS, García-Castillo A, Janion M, Nicolau JC, Fox KA, Morrow DA, Gibson CM, Antman EM. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial. American Heart Journal. 154: 54-61. PMID 17584551 DOI: 10.1016/j.ahj.2007.03.047  0.411
2007 Gibson CM, Ten Y, Murphy SA, Ciaglo LN, Southard MC, Lincoff AM, Waksman R. Association of Prerandomization Anticoagulant Switching With Bleeding in the Setting of Percutaneous Coronary Intervention (A REPLACE-2 Analysis) American Journal of Cardiology. 99: 1687-1690. PMID 17560876 DOI: 10.1016/j.amjcard.2007.01.053  0.374
2007 Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Journal of the American College of Cardiology. 49: 2238-46. PMID 17560287 DOI: 10.1016/J.Jacc.2007.01.093  0.451
2007 Tricoci P, Peterson ED, Chen AY, Newby LK, Harrington RA, Greenbaum AB, Cannon CP, Gibson CM, Hoekstra JW, Pollack CV, Ohman EM, Gibler WB, Roe MT. Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). The American Journal of Cardiology. 99: 1389-93. PMID 17493466 DOI: 10.1016/j.amjcard.2006.12.066  0.405
2007 Lee S, Gibson CM. Enoxaparin in acute coronary syndromes Expert Review of Cardiovascular Therapy. 5: 387-399. PMID 17489664 DOI: 10.1586/14779072.5.3.387  0.428
2007 Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED. Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery Annals of Thoracic Surgery. 83: 993-1001. PMID 17307447 DOI: 10.1016/j.athoracsur.2006.10.046  0.329
2007 Fernández-Avilés F, Alonso JJ, Peña G, Blanco J, Alonso-Briales J, López-Mesa J, Fernández-Vázquez F, Moreu J, Hernández RA, Castro-Beiras A, Gabriel R, Gibson CM, Sánchez PL. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. European Heart Journal. 28: 949-60. PMID 17244641 DOI: 10.1093/eurheartj/ehl461  0.402
2007 Yan AT, Gibson CM, Larose E, Anavekar NS, Tsang S, Solomon SD, Reynolds G, Kwong RY. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 8: 831-7. PMID 17060106 DOI: 10.1080/10976640600778049  0.358
2007 Bunting TA, Gibson CM. Advances in antithrombin and antiplatelet therapy for percutaneous coronary intervention Current Cardiovascular Risk Reports. 1: 284-289. DOI: 10.1007/s12170-007-0046-0  0.351
2006 Kugelmass AD, Sadanandan S, Lakkis N, Dibattiste PM, Robertson DH, Demopoulos LA, Gibson CM, Weintraub WS, Murphy SA, Cannon CP. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18. Critical Pathways in Cardiology. 5: 167-72. PMID 18340233 DOI: 10.1097/01.hpc.0000236218.07432.a6  0.392
2006 Kirtane AJ, Gibson CM. Distal Embolization of Thrombus in Acute Myocardial Infarction American Journal of Medicine. 119. PMID 17145234 DOI: 10.1016/j.amjmed.2006.08.019  0.37
2006 Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP, Antman EM, Cannon CP, Gibson CM. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 114: 2019-25. PMID 17075010 DOI: 10.1161/CIRCULATIONAHA.106.638353  0.378
2006 Gibson WJ, Gibson CM. The association of impaired myocardial perfusion and monocytosis with late recovery of left ventricular function following primary percutaneous coronary intervention European Heart Journal. 27: 2487-2488. PMID 17000630 DOI: 10.1093/eurheartj/ehl267  0.362
2006 Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, McCabe CH, Braunwald E. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30). American Heart Journal. 152: 756-61. PMID 16996854 DOI: 10.1016/J.Ahj.2006.04.016  0.459
2006 Gibson CM, Kirtane AJ, Murphy SA, Rohrbeck S, Menon V, Lins J, Kazziha S, Rokos I, Shammas NW, Palabrica TM, Fish P, McCabe CH, Braunwald E. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. American Heart Journal. 152: 668-75. PMID 16996831 DOI: 10.1016/J.Ahj.2006.06.003  0.453
2006 Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. American Heart Journal. 152: 641-7. PMID 16996828 DOI: 10.1016/J.AHJ.2006.02.035  0.425
2006 Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). American Heart Journal. 152: 627-35. PMID 16996826 DOI: 10.1016/J.Ahj.2006.04.012  0.437
2006 Kirtane AJ, Vafai JJ, Murphy SA, Aroesty JM, Sabatine MS, Cannon CP, Gibson CM. Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: A CLARITY-TIMI 28 substudy European Heart Journal. 27: 2040-2045. PMID 16847010 DOI: 10.1093/eurheartj/ehl149  0.384
2006 Scirica BM, Sabatine MS, Morrow DA, Gibson CM, Murphy SA, Wiviott SD, Giugliano RP, McCabe CH, Cannon CP, Braunwald E. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. Journal of the American College of Cardiology. 48: 37-42. PMID 16814646 DOI: 10.1016/J.Jacc.2006.02.052  0.35
2006 Deibele AJ, Kirtane AJ, Pinto DS, Lucca MJ, Neva C, Shui A, Murphy SA, Tcheng JE, Gibson CM. Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. Journal of Thrombosis and Thrombolysis. 22: 47-50. PMID 16786232 DOI: 10.1007/s11239-006-7454-8  0.443
2006 Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. Journal of the American College of Cardiology. 47: 2374-9. PMID 16781361 DOI: 10.1016/J.JACC.2005.09.080  0.419
2006 Gibson CM, Morrow DA, Murphy SA, Palabrica TM, Jennings LK, Stone PH, Lui HH, Bulle T, Lakkis N, Kovach R, Cohen DJ, Fish P, McCabe CH, Braunwald E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. Journal of the American College of Cardiology. 47: 2364-73. PMID 16781360 DOI: 10.1016/J.Jacc.2005.12.077  0.408
2006 Pinto DS, Southard M, Ciaglo L, Gibson CM. Door-to-balloon delays with percutaneous coronary intervention in ST-elevation myocardial infarction American Heart Journal. 151. PMID 16777506 DOI: 10.1016/j.ahj.2006.04.010  0.447
2006 Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. Journal of Clinical Hypertension (Greenwich, Conn.). 8: 315-22. PMID 16687939 DOI: 10.1111/J.1524-6175.2006.05384.X  0.418
2006 Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, French W, Blankenship J, Lui HH, Palabrica T, Jennings LK, et al. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. The American Journal of Cardiology. 97: 1473-7. PMID 16679086 DOI: 10.1016/J.Amjcard.2005.12.037  0.419
2006 Svensson L, Aasa M, Dellborg M, Gibson CM, Kirtane A, Herlitz J, Ohlsson A, Karlsson T, Grip L. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. American Heart Journal. 151: 798.e1-7. PMID 16569536 DOI: 10.1016/J.AHJ.2005.09.013  0.454
2006 Sabatine MS, Morrow DA, McCabe CH, Antman EM, Gibson CM, Cannon CP. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction American Heart Journal. 151: 25-31. PMID 16368287 DOI: 10.1016/j.ahj.2005.02.030  0.386
2006 Pérez de Prado A, Fernández-Vázquez F, Cuellas-Ramón JC, Gibson CM. Coronary Angiography: Beyond Coronary Anatomy Revista EspañOla De Cardiología (English Edition). 59: 596-608. DOI: 10.1016/S1885-5857(07)60010-3  0.33
2005 Pinto DS, Kirtane AJ, Ruocco NA, Deibele AJ, Shui A, Buros J, Murphy SA, Gibson CM. Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. The American Journal of Cardiology. 96: 1494-7. PMID 16310428 DOI: 10.1016/J.AMJCARD.2005.07.056  0.447
2005 Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation. 112: 3846-54. PMID 16291601 DOI: 10.1161/Circulationaha.105.595397  0.401
2005 Ly HQ, Denault A, Dupuis J, Vadeboncoeur A, Harel F, Arsenault A, Gibson CM, Bonan R. A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study). American Heart Journal. 150: 933. PMID 16290966 DOI: 10.1016/J.Ahj.2005.02.049  0.418
2005 Shavelle DM, Rasouli ML, Frederick P, Gibson CM, French WJ. Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis). The American Journal of Cardiology. 96: 1227-32. PMID 16253587 DOI: 10.1016/j.amjcard.2005.06.061  0.394
2005 Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, Cannon CP. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). The American Journal of Cardiology. 96: 635-8. PMID 16125484 DOI: 10.1016/J.Amjcard.2005.04.033  0.33
2005 Ohman EM, Werf FVd, Antman EM, Califf RM, Lemos JAd, Gibson CM, Oliverio RL, Harrelson L, McCabe C, DiBattiste P, Braunwald E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial American Heart Journal. 150: 79-88. PMID 16084152 DOI: 10.1016/J.Ahj.2005.01.007  0.311
2005 Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 46: 178-80. PMID 15992655 DOI: 10.1016/J.Jacc.2005.03.052  0.361
2005 Giugliano RP, Newby LK, Harrington RA, Gibson CM, Werf FVd, Armstrong P, Montalescot G, Gilbert J, Strony JT, Califf RM, Braunwald E. The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale ☆ ☆☆ American Heart Journal. 149: 994-1002. PMID 15976780 DOI: 10.1016/J.Ahj.2005.03.029  0.44
2005 Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. Journal of the American College of Cardiology. 45: 1781-6. PMID 15936606 DOI: 10.1016/J.Jacc.2005.02.068  0.327
2005 Mega JL, Morrow DA, Sabatine MS, Zhao XQ, Snapinn SM, Dibattiste PM, Gibson CM, Antman EM, Braunwald E, Théroux P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial American Heart Journal. 149: 846-850. PMID 15894966 DOI: 10.1016/J.Ahj.2004.08.042  0.377
2005 Jeremias A, Gibson CM. Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded Annals of Internal Medicine. 142: 786-791. PMID 15867411 DOI: 10.7326/0003-4819-142-9-200505030-00015  0.41
2005 Sabatine MS, McCabe CH, Gibson CM, Cannon CP. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial American Heart Journal. 149: 227-233. PMID 15846259 DOI: 10.1016/j.ahj.2004.11.006  0.438
2005 Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 111: 2042-9. PMID 15824203 DOI: 10.1161/01.Cir.0000162477.70955.5F  0.373
2005 Sabatine MS, Blake GJ, Drazner MH, Morrow DA, Scirica BM, Murphy SA, McCabe CH, Weintraub WS, Gibson CM, Cannon CP. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment. Circulation. 111: 1217-24. PMID 15769761 DOI: 10.1161/01.CIR.0000157733.50479.B9  0.393
2005 Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. The New England Journal of Medicine. 352: 1179-89. PMID 15758000 DOI: 10.1056/Nejmoa050522  0.423
2005 Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients. Journal of the American College of Cardiology. 45: 357-62. PMID 15680712 DOI: 10.1016/J.Jacc.2004.10.047  0.435
2005 Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Predictors of the rise in vWF after ST elevation myocardial infarction: Implications for treatment strategies and clinical outcome. An ENTIRE-TIMI 23 substudy European Heart Journal. 26: 440-446. PMID 15673542 DOI: 10.1093/Eurheartj/Ehi104  0.431
2005 Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CM. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. The American Journal of Cardiology. 95: 383-6. PMID 15670549 DOI: 10.1016/J.AMJCARD.2004.09.038  0.453
2005 Kirtane AJ, Kosmidou I, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. The American Journal of Cardiology. 95: 337-42. PMID 15670541 DOI: 10.1016/J.Amjcard.2004.09.030  0.438
2005 Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 45: 321-3. PMID 15653037 DOI: 10.1016/J.Jacc.2004.10.018  0.342
2005 Kashani A, Gibson CM, Murphy SA, Sabatine MS, Morrow DA, Antman EM, Giugliano RP. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction American Journal of Cardiology. 95: 228-233. PMID 15642555 DOI: 10.1016/j.amjcard.2004.08.092  0.423
2005 Kirtane AJ, Weisbord A, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Ohman EM, Roe MT, Braunwald E, Gibson CM. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. The American Journal of Cardiology. 95: 224-7. PMID 15642554 DOI: 10.1016/J.Amjcard.2004.09.007  0.406
2005 Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. The American Journal of Cardiology. 94: 1406-10. PMID 15566912 DOI: 10.1016/J.Amjcard.2004.08.015  0.413
2005 Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. European Heart Journal. 25: 1998-2005. PMID 15541835 DOI: 10.1016/J.Ehj.2004.08.016  0.394
2005 Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. The American Journal of Cardiology. 94: 1113-7. PMID 15518603 DOI: 10.1016/J.Amjcard.2004.07.075  0.385
2005 Sabatine M, Cannon C, Gibson C. Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics: The PCI-CLARITY Study Acc Current Journal Review. 14: 2. DOI: 10.1016/J.ACCREVIEW.2005.11.008  0.45
2005 Sabatine M, Cannon C, Gibson C. Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation Acc Current Journal Review. 14: 1. DOI: 10.1016/J.ACCREVIEW.2005.05.016  0.344
2005 Gibson C, Dumaine R, Gelfand E. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials Acc Current Journal Review. 14: 11. DOI: 10.1016/J.ACCREVIEW.2005.03.006  0.388
2005 Sabatine M, Cannon C, Gibson C. Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics: The PCI-CLARITY Study Acc Current Journal Review. 14: 2. DOI: 10.1001/Jama.294.10.1224  0.448
2004 Herrmann HC, Murphy SA, Dibattiste PM, Delucca PT, Demopoulos LA, Gibson CM, Cannon CP. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy. Critical Pathways in Cardiology. 3: 95-100. PMID 18340148 DOI: 10.1097/01.Hpc.0000131548.11420.86  0.38
2004 Karha J, Gibson CM, Murphy SA, DiBattiste PM, Cannon CP. Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction American Journal of Cardiology. 94: 1537-1539. PMID 15589011 DOI: 10.1016/j.amjcard.2004.08.033  0.381
2004 Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Jama. 292: 2096-104. PMID 15523070 DOI: 10.1001/Jama.292.17.2096  0.369
2004 Sadanandan S, Cannon CP, Chekuri K, Murphy SA, DiBattiste PM, Morrow DA, Lemos JAd, Braunwald E, Gibson CM. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 44: 564-568. PMID 15358021 DOI: 10.1016/J.Jacc.2004.03.072  0.404
2004 Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Gibson CM. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction. Journal of Thrombosis and Thrombolysis. 17: 177-84. PMID 15353915 DOI: 10.1023/B:THRO.0000040486.10549.f6  0.355
2004 Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction Journal of the American College of Cardiology. 44: 980-987. PMID 15337207 DOI: 10.1016/J.Jacc.2004.05.059  0.379
2004 Gibson CM, Singh KP, Murphy SA, DiBattiste PM, Demopoulos LA, Cannon CP, Braunwald E. Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) American Journal of Cardiology. 94: 492-494. PMID 15325937 DOI: 10.1016/J.Amjcard.2004.04.066  0.421
2004 Sadanandan S, Cannon CP, Gibson CM, Murphy SA, Dibattiste PM, Braunwald E. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction Journal of the American College of Cardiology. 44: 799-803. PMID 15312862 DOI: 10.1016/J.Jacc.2004.03.081  0.387
2004 Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, Cannon CP, Antman EM, Braunwald E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 44: 783-9. PMID 15312859 DOI: 10.1016/J.Jacc.2004.05.045  0.368
2004 Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. American Heart Journal. 148: 336-40. PMID 15309006 DOI: 10.1016/J.Ahj.2003.12.044  0.437
2004 Gibson CM, Jennings LK, Murphy SA, Lorenz DP, Giugliano RP, Harrington RA, Cholera S, Krishnan R, Califf RM, Braunwald E. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy. Circulation. 110: 679-84. PMID 15262838 DOI: 10.1161/01.Cir.0000137912.11655.F6  0.339
2004 Mega JL, Morrow DA, Lemos JAd, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. Journal of the American College of Cardiology. 44: 335-339. PMID 15261928 DOI: 10.1016/J.Jacc.2004.04.033  0.401
2004 Gardner GS, Frisch DR, Murphy SA, Kirtane AJ, Giugliano RP, Antman EM, Braunwald E, Gibson CM. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. The American Journal of Cardiology. 94: 178-81. PMID 15246895 DOI: 10.1016/J.Amjcard.2004.03.057  0.363
2004 Gibson CM, Schömig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion Circulation. 109: 3096-3105. PMID 15226226 DOI: 10.1161/01.CIR.0000134278.50359.CB  0.406
2004 Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction. The American Journal of Cardiology. 94: 108-11. PMID 15219518 DOI: 10.1016/J.AMJCARD.2004.03.038  0.372
2004 Giugliano RP, Sabatine MS, Gibson CM, Roe MT, Harrington RA, Murphy SA, Morrow DA, Antman EM, Braunwald E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. The American Journal of Cardiology. 93: 1362-7, A5-6. PMID 15165915 DOI: 10.1016/J.Amjcard.2004.02.031  0.448
2004 Gibson CM, Karha J, Giugliano RP, Roe MT, Murphy SA, Harrington RA, Green CL, Schweiger MJ, Miklin JS, Baran KW, Palmeri S, Braunwald E, Krucoff MW. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. American Heart Journal. 147: 847-52. PMID 15131541 DOI: 10.1016/J.Ahj.2003.11.015  0.395
2004 McCullough PA, Gibson CM, Dibattiste PM, Demopoulos LA, Murphy SA, Weintraub WS, Neumann FJ, Khanal S, Cannon CP. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial. Journal of Interventional Cardiology. 17: 81-6. PMID 15104769 DOI: 10.1111/j.1540-8183.2004.021001.x  0.425
2004 Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi MJ. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 61: 472-6. PMID 15065140 DOI: 10.1002/ccd.20024  0.333
2004 Gibson CM, Karha J, Murphy SA, Lemos JAd, Morrow DA, Giugliano RP, Roe MT, Harrington RA, Cannon CP, Antman EM, Califf RM, Braunwald E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. Journal of the American College of Cardiology. 43: 1170-1176. PMID 15063425 DOI: 10.1016/J.Jacc.2003.11.035  0.339
2004 Kirtane AJ, Bui A, Murphy SA, Barron HV, Gibson CM. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. The American Journal of Cardiology. 93: 532-6. PMID 14996574 DOI: 10.1016/j.amjcard.2003.11.013  0.424
2004 Roe MT, Green CL, Giugliano RP, Gibson CM, Baran K, Greenberg M, Palmeri ST, Crater S, Trollinger K, Hannan K, Harrington RA, Krucoff MW. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 43: 549-56. PMID 14975462 DOI: 10.1016/j.jacc.2003.09.039  0.343
2004 Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 109: 580-6. PMID 14769678 DOI: 10.1161/01.Cir.0000109491.66226.26  0.399
2004 Gibson CM, Kirtane AJ, Murphy SA, Karha J, Cannon CP, Giugliano RP, Roe MT, Harrington RA, Ohman EM, Antman EM. Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture. Journal of Thrombosis and Thrombolysis. 15: 189-96. PMID 14739628 DOI: 10.1023/B:THRO.0000011374.60110.bc  0.408
2004 Wiviott SD, Sabatine MS, Morrow DA, Dumaine R, Murphy SA, Boundy KE, Cannon CP, Gibson C. 1118-82 Distinct modes of cardiovascular death associated with impaired epicardial and myocardial perfusion following fibrinolysis for ST elevation myocardial infarction Journal of the American College of Cardiology. 43: A290-A291. DOI: 10.1016/S0735-1097(04)91230-2  0.344
2004 Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, McCabe CH, Gibson C, Cannon CP, Antman EM, Braunwald E. 1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes Journal of the American College of Cardiology. 43: A278. DOI: 10.1016/S0735-1097(04)91180-1  0.317
2004 Kirtane AJ, Karmpaliotis D, Weisbord A, Bui A, Murphy SA, Budiu D, Kosmidou I, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson C. 1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries Journal of the American College of Cardiology. 43: A262. DOI: 10.1016/S0735-1097(04)91114-X  0.394
2004 Karmpaliotis D, Kirtane AJ, Murphy SA, Kosmidou I, Budiu D, Guerra D, Giugliano R, Cannon CP, Antman EM, Braunwald E, Gibson C. 1060-83 Calcification of the culprit lesion is associated with adverse clinical outcomes in ST elevation myocardial infarction patients treated with fibrinolytic therapy Journal of the American College of Cardiology. 43: A261-A262. DOI: 10.1016/S0735-1097(04)91112-6  0.357
2004 Dumaine R, Gibson C, Pinto DS, Murphy SA, Morrow DA, Hobbach H, Wiviott SD, Cannon CP, Antman EM, Braunwald E. 1021-101 Association of glomerular filtration rate on presentation with subsequent mortality in non-ST elevation acute coronary syndromes Journal of the American College of Cardiology. 43: A250. DOI: 10.1016/S0735-1097(04)91062-5  0.326
2004 Gibson CM. NRMI and current treatment patterns for ST-elevation myocardial infarction American Heart Journal. 148. DOI: 10.1016/j.ahj.2004.09.012  0.385
2003 Dumaine R, Bigelow B, Aroesty J, Gibson CM. Myocardial reperfusion: its assessment and its relation to clinical outcomes The American Heart Hospital Journal. 1: 120-127. PMID 15815131 DOI: 10.1111/J.1541-9215.2003.02348.X  0.369
2003 Hobbach HP, Gibson CM, Giugliano RP, Hundertmark J, Schaeffer C, Tscherleniak W, Schuster P. The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction. Journal of Thrombosis and Thrombolysis. 16: 167-74. PMID 15087603 DOI: 10.1023/B:THRO.0000024055.13207.50  0.424
2003 Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. Journal of the American College of Cardiology. 42: 1535-43. PMID 14607434 DOI: 10.1016/J.Jacc.2003.06.001  0.374
2003 Karha J, Murphy SA, Kirtane AJ, Lemos JAd, Aroesty JM, Cannon CP, Antman EM, Braunwald E, Gibson CM. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction American Journal of Cardiology. 92: 913-918. PMID 14556865 DOI: 10.1016/S0002-9149(03)00969-X  0.302
2003 Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Dauterman KW, Michaels A, Barron HV, Antman EM. Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. Journal of Thrombosis and Thrombolysis. 14: 233-7. PMID 12913404 DOI: 10.1023/A:1025004911375  0.415
2003 Varo N, Lemos JAd, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 108: 1049-1052. PMID 12912804 DOI: 10.1161/01.Cir.0000088521.04017.13  0.33
2003 Gibson CM. Has my patient achieved adequate myocardial reperfusion? Circulation. 108: 504-507. PMID 12900495 DOI: 10.1161/01.CIR.0000082932.69023.74  0.355
2003 Murphy SA, Dauterman K, Lemos JAd, Kermgard S, Antman EM, Braunwald E, Gibson CM. Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial American Heart Journal. 146: 42-47. PMID 12851606 DOI: 10.1016/S0002-8703(03)00145-5  0.367
2003 Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, Giugliano RP, Antman EM, Braunwald E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. Journal of the American College of Cardiology. 42: 7-16. PMID 12849652 DOI: 10.1016/S0735-1097(03)00506-0  0.349
2003 Wong GC, Frisch D, Murphy SA, Sabatine MS, Pai R, James D, Kraimer N, Katsiyiannis PT, Marble SJ, DiBattiste PM, Demopoulos LA, Gourlay SG, Barron HV, Cannon CP, Gibson CM, et al. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction. The American Journal of Cardiology. 91: 1163-7. PMID 12745096 DOI: 10.1016/S0002-9149(03)00260-1  0.394
2003 Guerra DR, Karha J, Gibson CM. Safety and efficacy of tenecteplase in acute myocardial infarction Expert Opinion On Pharmacotherapy. 4: 791-798. PMID 12740001 DOI: 10.1517/14656566.4.5.791  0.319
2003 Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction American Journal of Cardiology. 91: 1055-1059. PMID 12714146 DOI: 10.1016/S0002-9149(03)00148-6  0.332
2003 Morrow DA, Lemos JAd, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Gibson CM, Cannon CP, Braunwald E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. Journal of the American College of Cardiology. 41: 1264-1272. PMID 12706919 DOI: 10.1016/S0735-1097(03)00168-2  0.304
2003 Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, Baran KW, Hobbach HP, Woodlief LH, Hannan KL, Greenberg S, Miller J, Kitt MM, Strony J, McCabe CH, et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. Journal of the American College of Cardiology. 41: 1251-60. PMID 12706917 DOI: 10.1016/S0735-1097(03)00123-2  0.332
2003 Pinto DS, Lorenz DP, Murphy SA, Marble SJ, DiBattiste PM, Demopoulos LA, Cannon CP, Gibson CM. Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy). The American Journal of Cardiology. 91: 976-8, A4. PMID 12686341 DOI: 10.1016/S0002-9149(03)00117-6  0.314
2003 Lemos JAd, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes Circulation. 107: 690-695. PMID 12578870 DOI: 10.1161/01.Cir.0000049742.68848.99  0.413
2003 Murphy SA, Chen C, Gourlay SG, Gibbons RJ, Barron HV, Gibson CM. Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy. The American Journal of Cardiology. 91: 325-8. PMID 12565089 DOI: 10.1016/S0002-9149(02)03160-0  0.387
2003 Angeja BG, Kermgard S, Chen MS, McKay M, Murphy SA, Antman EM, Cannon CP, Braunwald E, Gibson CM. The smoker's paradox: insights from the angiographic substudies of the TIMI trials. Journal of Thrombosis and Thrombolysis. 13: 133-9. PMID 12355029 DOI: 10.1023/A:1020470721977  0.381
2003 Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes ☆: A TACTICS-TIMI 18 substudy Journal of the American College of Cardiology. 40: 1761-1768. DOI: 10.1016/S1062-1458(03)00020-5  0.461
2003 Wiviott SD, Cannon CP, Morrow DA, Sabatine MS, Murphy SA, Rafai N, DiBattiste PM, Gibson C, McCabe CH, Braunwald E. Gender differences in cardiac biomarkers in patients with unstable angina and non-ST elevation myocardial infarction in TACTICS-TIMI 18 Journal of the American College of Cardiology. 41: 341. DOI: 10.1016/S0735-1097(03)82046-6  0.36
2003 Giugliano RP, Sabatine MS, Gibson C, Roe MT, Harrington RA, Pisapia G, Morrow DA, Antman EM, Braunwald E. A new endpoint to evaluate the sucess of reperfusion therapy following ST-elevation myocardial infarction Journal of the American College of Cardiology. 41: 392. DOI: 10.1016/S0735-1097(03)81127-0  0.336
2003 Sadanandan S, Cannon CP, Gibson C, Desai R, Murphy SA, DiBattiste PM, Braunwald E. A risk score for predicting coronary artery bypass surgery in patients with non-ST elevation acute coronary syndromes Journal of the American College of Cardiology. 41: 391. DOI: 10.1016/S0735-1097(03)81124-5  0.355
2003 Gibson C, Karha J, Murphy S. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials Acc Current Journal Review. 12: 16. DOI: 10.1016/j.accreview.2003.08.053  0.307
2002 Weber JE, Hollander JE, Murphy SA, Braunwald E, Gibson CM. Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use Journal of Thrombosis and Thrombolysis. 14: 239-245. PMID 12913405 DOI: 10.1023/A:1025056912284  0.32
2002 Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. Journal of the American College of Cardiology. 40: 1761-1768. PMID 12446059 DOI: 10.1016/S0735-1097(02)02484-1  0.455
2002 Sharis PJ, Cannon CP, Rogers WJ, McCabe C, Murphy S, Gibson CM, Stone PH, Braunwald E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry). The American Journal of Cardiology. 90: 1154-6. PMID 12423724 DOI: 10.1016/S0002-9149(02)02788-1  0.424
2002 Cooper HA, Lemos JAd, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Gibson CM, Antman EM, Braunwald E. Minimal ST-segment deviation: A simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration American Heart Journal. 144: 790-795. PMID 12422146 DOI: 10.1067/Mhj.2002.125618  0.405
2002 Angeja BG, Lemos JAd, Murphy SA, Marble SJ, Antman EM, Cannon CP, Braunwald E, Gibson CM. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy American Heart Journal. 144: 649-656. PMID 12360161 DOI: 10.1067/Mhj.2002.124869  0.323
2002 Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 57: 125-34. PMID 12357506 DOI: 10.1002/ccd.10313  0.392
2002 Murphy SA, Chen C, Cannon CP, Antman EM, Gibson CM. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction American Journal of Cardiology. 90: 766-770. PMID 12356395 DOI: 10.1016/S0002-9149(02)02608-5  0.357
2002 Brener SJ, Murphy SA, Gibson CM, DiBattiste PM, Demopoulos LA, Cannon CP. Efficacy and safety of multivessel percutaneous revascularization and Tirofiban therapy in patients with acute coronary syndromes American Journal of Cardiology. 90: 631-633. PMID 12231091 DOI: 10.1016/S0002-9149(02)02569-9  0.359
2002 Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, McCabe CH, Gibson CM, Braunwald E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. The American Journal of Cardiology. 90: 303-5. PMID 12127617 DOI: 10.1016/S0002-9149(02)02468-2  0.399
2002 de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Sabatine MS, Rifai N, McCabe CH, Antman EM, Cannon CP, Braunwald E. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. Journal of the American College of Cardiology. 40: 238-44. PMID 12106926 DOI: 10.1016/S0735-1097(02)01948-4  0.36
2002 Wong GC, Morrow DA, Murphy S, Kraimer N, Pai R, James D, Robertson DH, Demopoulos LA, DiBattiste P, Cannon CP, Gibson CM. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation. 106: 202-7. PMID 12105159 DOI: 10.1161/01.CIR.0000021921.14653.28  0.373
2002 Gibson CM, Dotani MI, Murphy SA, Marble SJ, Dauterman KW, Michaels AD, Dodge JT. Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. American Heart Journal. 144: 130-5. PMID 12094199 DOI: 10.1067/MHJ.2002.123142  0.39
2002 Antman EM, Cooper HA, Gibson CM, Lemos JAd, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Werf FVd, Braunwald E. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. European Heart Journal. 23: 928-933. PMID 12069446 DOI: 10.1053/Euhj.2001.2964  0.346
2002 Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 105: 1909-13. PMID 11997276 DOI: 10.1161/01.Cir.0000014683.52177.B5  0.361
2002 Gibson CM, Chen M, Angeja BG, Murphy SA, Marble SJ, Barron HV, Cannon CP. Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery Journal of Thrombosis and Thrombolysis. 13: 9-12. PMID 11994554 DOI: 10.1023/A:1015355722670  0.367
2002 Sabatine MS, Morrow DA, Lemos JAd, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide Circulation. 105: 1760-1763. PMID 11956114 DOI: 10.1161/01.Cir.0000015464.18023.0A  0.365
2002 Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 105: 1642-9. PMID 11940541 DOI: 10.1161/01.Cir.0000013402.34759.46  0.356
2002 Angeja BG, Gunda M, Murphy SA, Sobel BE, Rundle AC, Syed M, Asfour A, Borzak S, Gourlay SG, Barron HV, Gibbons RJ, Gibson CM. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation. 105: 282-5. PMID 11804979 DOI: 10.1161/hc0302.103588  0.351
2002 Gibson CM, Murphy SA, Marble SJ, Cohen DJ, Cohen EA, Lui HK, Young J, Kitt MM, Lorenz TJ, Tcheng JE. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy. American Heart Journal. 143: 106-10. PMID 11773919 DOI: 10.1067/MHJ.2002.119618  0.332
2002 Marks DS, Gudapati SB, Kleczka JF, Murphy SA, Cannon CP, Braunwald E, Gibson C. Electrocardiographic left ventricular hypertrophy is associated with mortality and left ventricular rupture in patients with acute myocardial infarction Journal of the American College of Cardiology. 39: 331. DOI: 10.1016/S0735-1097(02)81487-5  0.312
2001 Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, Gibbons RJ, Borzak S, Sobel BE, Gourlay SG, Rundle AC, Gibson CM, Barron HV. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 104: 2778-83. PMID 11733394  0.321
2001 Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, Changezi HU, Antman EM, Braunwald E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). The American Journal of Cardiology. 88: 831-6. PMID 11676942 DOI: 10.1016/S0002-9149(01)01887-2  0.436
2001 Appleby MA, Angeja BG, Dauterman K, Gibson CM. Angiographic assessment of myocardial perfusion: TIMI myocardial perfusion (TMP) grading system. Heart (British Cardiac Society). 86: 485-6. PMID 11602533 DOI: 10.1136/heart.86.5.485  0.341
2001 Angeja BG, Gibson CM, Chin R, Canto JG, Barron HV. Use of reperfusion therapies in elderly patients with acute myocardial infarction Drugs and Aging. 18: 587-596. PMID 11587245 DOI: 10.2165/00002512-200118080-00003  0.359
2001 Lemos JAd, Morrow DA, Gibson CM, Murphy SA, Rifai N, Tanasijevic M, Giugliano RP, Schuhwerk KC, McCabe CH, Cannon CP, Antman EM, Braunwald E. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy American Journal of Cardiology. 88: 353-358. PMID 11545753 DOI: 10.1016/S0002-9149(01)01678-2  0.35
2001 Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HS. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. American Heart Journal. 142: 29-36. PMID 11431653 DOI: 10.1067/Mhj.2001.116068  0.329
2001 Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. The New England Journal of Medicine. 344: 1879-87. PMID 11419424 DOI: 10.1056/Nejm200106213442501  0.381
2001 Gibson CM, Lemos JAd, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E. Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction A TIMI 14 Substudy Circulation. 103: 2550-2554. PMID 11382722 DOI: 10.1161/01.Cir.103.21.2550  0.39
2001 Gibson CM, Cohen DJ, Cohen EA, Lui HK, Murphy SA, Marble SJ, Kitt M, Lorenz T, Tcheng JE. Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. The American Journal of Cardiology. 87: 1293-5. PMID 11377359 DOI: 10.1016/S0002-9149(01)01524-7  0.302
2001 Gibson CM, Kirtane AJ, Murphy SA, Marble SJ, Lemos JAd, Antman EM, Braunwald E. Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction. Catheterization and Cardiovascular Interventions. 53: 6-11. PMID 11329210 DOI: 10.1002/Ccd.1121  0.33
2001 de Lemos JA, Gibson CM, Antman EM, Murphy SA, Morrow DA, Schuhwerk KC, Schweiger M, Coussement P, Van de Werf F, Braunwald E. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial. American Heart Journal. 141: 592-8. PMID 11275925 DOI: 10.1067/Mhj.2001.113574  0.465
2001 Roe MT, Giugliano RP, Harrington RA, Gibson CM, Strony J, Kitt MM, Califf RM, Braunwald E. Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction Heart Drug. 1: 5-13. DOI: 10.1159/000022704  0.369
2000 Gibson CM, Anshelevich M, Murphy S, Luu L, Hynes C, Kliris J, Kermgard S, Otten MH, Antman EM, Cannon CP, Braunwald E. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction. The American Journal of Cardiology. 86: 1378-9, A5. PMID 11113418 DOI: 10.1016/S0002-9149(00)01248-0  0.328
2000 Gibson CM. A union in reperfusion: The concept of facilitated percutaneous coronary intervention Journal of the American College of Cardiology. 36: 1497-1499. PMID 11079648 DOI: 10.1016/S0735-1097(00)00926-8  0.338
2000 Lemos JAd, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Werf FVd, Gibson CM, Braunwald E. St-segment resolution and infarct-related artery patency and flow after thrombolytic therapy American Journal of Cardiology. 85: 299-304. PMID 11078296 DOI: 10.1016/S0002-9149(99)00736-5  0.39
2000 Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: Focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon American Journal of Cardiology. 85: 50-60. PMID 11076131 DOI: 10.1016/S0002-9149(00)00811-0  0.404
2000 Dotani MI, Elnicki DM, Jain AC, Gibson CM. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting American Journal of Cardiology. 86: 1128-1130. PMID 11074212 DOI: 10.1016/S0002-9149(00)01172-3  0.307
2000 de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, Schuhwerk KC, Arslanian S, McCabe CH, Gibson CM, Rifai N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clinica Chimica Acta; International Journal of Clinical Chemistry. 298: 85-97. PMID 10876006 DOI: 10.1016/S0009-8981(00)00259-X  0.306
2000 Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. Jama. 283: 2941-7. PMID 10865271 DOI: 10.1001/JAMA.283.22.2941  0.347
2000 Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, Gibson CM. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials) American Journal of Cardiology. 85: 1409-1413. PMID 10856384 DOI: 10.1016/S0002-9149(00)00786-4  0.387
2000 Dauerman HL, Pinto DS, Ho KK, Gibson CM, Kuntz RE, Cohen DJ, Baim DS, Carrozza JP. Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 49: 237-43. PMID 10700048 DOI: 10.1002/(SICI)1522-726X(200003)49:3<237::AID-CCD1>3.0.CO;2-7  0.394
2000 de Lemos JA, Antman EM, Gibson CM, McCabe CH, Giugliano RP, Murphy SA, Coulter SA, Anderson K, Scherer J, Frey MJ, Van Der Wieken R, Van De Werf F, Braunwald E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation. 101: 239-43. PMID 10645918 DOI: 10.1161/01.Cir.101.3.239  0.383
2000 Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van De Werf F, Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation. 101: 125-130. PMID 10637197 DOI: 10.1161/01.Cir.101.2.125  0.314
1999 Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. Journal of the American College of Cardiology. 34: 1403-12. PMID 10551685 DOI: 10.1016/S0735-1097(99)00397-6  0.3
1999 Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. Journal of the American College of Cardiology. 34: 739-47. PMID 10483955 DOI: 10.1016/S0735-1097(99)00274-0  0.393
1999 Gibson CM. Primary angioplasty compared with thrombolysis: New issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting Annals of Internal Medicine. 130: 841-847. PMID 10366375 DOI: 10.7326/0003-4819-130-10-199905180-00019  0.358
1999 Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation. 99: 2720-32. PMID 10351964 DOI: 10.1161/01.Cir.99.21.2720  0.316
1999 Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results American Heart Journal. 137: 1179-1185. PMID 10347349 DOI: 10.1016/S0002-8703(99)70380-7  0.308
1999 Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, Cannon CP, Van De Werf F, Braunwald E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration Circulation. 99: 1945-1950. PMID 10208996 DOI: 10.1161/01.Cir.99.15.1945  0.302
1998 Gibson CM, Goel M, Cohen DJ, Piana RN, Deckelbaum LI, Harris KE, King SB. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Journal of the American College of Cardiology. 32: 28-34. PMID 9669245 DOI: 10.1016/S0735-1097(98)00192-2  0.335
1998 Dodge JT, Rizzo M, Nykiel M, Altmann J, Hobkirk K, Brennan M, Gibson CM. Impact of injection rate on the Thrombolysis in Myocardial Infarction (TIMI) trial frame count. The American Journal of Cardiology. 81: 1268-70. PMID 9604968 DOI: 10.1016/S0002-9149(98)00138-6  0.34
1998 Al-Mousa EN, Dodge JT, Rizzo M, McLean C, Ryan K, Moynihan J, Kelley M, Marble SJ, Goel M, Daley WL, Gibson CM. Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts. American Heart Journal. 135: 323-8. PMID 9489983 DOI: 10.1016/S0002-8703(98)70100-0  0.372
1998 Cannon C, Antman E, Gibson C, Paul S, Braunwald E. Critical pathway for acute ST segment elevation myocardial infarction: evaluation of the potential impact in the TIMI 9 registry Journal of the American College of Cardiology. 31: 192. DOI: 10.1016/S0735-1097(98)81474-5  0.35
1997 Tanasijevic MJ, Cannon CP, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Antman EM, Braunwald E. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. American Heart Journal. 134: 622-30. PMID 9351728 DOI: 10.1016/S0002-8703(97)70044-9  0.339
1997 Gibson CM, Marble SJ, Rizzo MJ, Moynihan J, McLean C, Ryan K, Sparano A, Piana RN, McCabe C, Cannon CP. Relation between injections before 90-minute angiography and coronary patency: Results of the thrombolysis in myocardial infarction 4 trial American Heart Journal. 134: 351-354. PMID 9327688 DOI: 10.1016/S0002-8703(97)70067-X  0.317
1997 Gibson CM, Cannon CP, Greene RM, Sequeira RF, Margorien RD, Leya F, Diver DJ, Baim DS, Braunwald E. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. The American Journal of Cardiology. 80: 21-6. PMID 9205014 DOI: 10.1016/S0002-9149(97)00277-4  0.431
1996 Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 93: 879-88. PMID 8598078 DOI: 10.1161/01.CIR.93.5.879  0.346
1995 Gibson CM, Cannon CP, Piana RN, Breall JA, Sharaf B, Flatley M, Alexander B, Diver DJ, McCabe CH, Flaker GC, Baim DS, Braunwald E. Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial Journal of the American College of Cardiology. 25: 582-589. PMID 7860900 DOI: 10.1016/0735-1097(94)00423-N  0.334
1994 Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP, Kuntz RE, Baim DS. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation. 89: 2514-8. PMID 8205658 DOI: 10.1161/01.CIR.89.6.2514  0.367
1994 Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients American Heart Journal. 128: 252-255. PMID 8037090 DOI: 10.1016/0002-8703(94)90476-6  0.37
1994 Gordon PC, Friedrich SP, Piana RN, Kugelmass AD, Leidig GA, Gibson CM, Cohen DJ, Carrozza JP, Kuntz RE, Baim DS. Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant? The American Journal of Cardiology. 74: 26-32. PMID 8017301 DOI: 10.1016/0002-9149(94)90486-3  0.304
Show low-probability matches.